<?properties open_access?>
<?DTDIdentifier.IdentifierValue -//Springer-Verlag//DTD A++ V2.4//EN?>
<?DTDIdentifier.IdentifierType public?>
<?SourceDTD.DTDName A++V2.4.dtd?>
<?SourceDTD.Version 2.4?>
<?ConverterInfo.XSLTName springer2nlmx2.xsl?>
<?ConverterInfo.Version 1?>
<processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
  <restricted-by>pmc</restricted-by>
</processing-meta>
<front>
  <journal-meta>
    <journal-id journal-id-type="nlm-ta">Sci Rep</journal-id>
    <journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id>
    <journal-title-group>
      <journal-title>Scientific Reports</journal-title>
    </journal-title-group>
    <issn pub-type="epub">2045-2322</issn>
    <publisher>
      <publisher-name>Nature Publishing Group UK</publisher-name>
      <publisher-loc>London</publisher-loc>
    </publisher>
  </journal-meta>
  <article-meta>
    <article-id pub-id-type="pmcid">9763336</article-id>
    <article-id pub-id-type="pmid">36535969</article-id>
    <article-id pub-id-type="publisher-id">24404</article-id>
    <article-id pub-id-type="doi">10.1038/s41598-022-24404-1</article-id>
    <article-categories>
      <subj-group subj-group-type="heading">
        <subject>Article</subject>
      </subj-group>
    </article-categories>
    <title-group>
      <article-title>ACPred-BMF: bidirectional LSTM with multiple feature representations for explainable anticancer peptide prediction</article-title>
    </title-group>
    <contrib-group>
      <contrib contrib-type="author">
        <name>
          <surname>Han</surname>
          <given-names>Bingqing</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zhao</surname>
          <given-names>Nan</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author">
        <name>
          <surname>Zeng</surname>
          <given-names>Chengshi</given-names>
        </name>
        <xref ref-type="aff" rid="Aff1">1</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Mu</surname>
          <given-names>Zengchao</given-names>
        </name>
        <address>
          <email>muzengchao@sdu.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff2">2</xref>
      </contrib>
      <contrib contrib-type="author" corresp="yes">
        <name>
          <surname>Gong</surname>
          <given-names>Xinqi</given-names>
        </name>
        <address>
          <email>xinqigong@ruc.edu.cn</email>
        </address>
        <xref ref-type="aff" rid="Aff1">1</xref>
        <xref ref-type="aff" rid="Aff3">3</xref>
      </contrib>
      <aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="GRID">grid.24539.39</institution-id><institution-id institution-id-type="ISNI">0000 0004 0368 8103</institution-id><institution>Institute for Mathematical Sciences, </institution><institution>Renmin University of China, </institution></institution-wrap>Beijing, 100872 China </aff>
      <aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="GRID">grid.27255.37</institution-id><institution-id institution-id-type="ISNI">0000 0004 1761 1174</institution-id><institution>School of Mathematics and Statistics, </institution><institution>Shandong University, </institution></institution-wrap>Weihai, 264209 China </aff>
      <aff id="Aff3"><label>3</label><institution-wrap><institution-id institution-id-type="GRID">grid.511045.4</institution-id><institution>Beijing Academy of Artificial Intelligence, </institution></institution-wrap>Beijing, 100083 China </aff>
    </contrib-group>
    <pub-date pub-type="epub">
      <day>19</day>
      <month>12</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="pmc-release">
      <day>19</day>
      <month>12</month>
      <year>2022</year>
    </pub-date>
    <pub-date pub-type="collection">
      <year>2022</year>
    </pub-date>
    <volume>12</volume>
    <elocation-id>21915</elocation-id>
    <history>
      <date date-type="received">
        <day>30</day>
        <month>4</month>
        <year>2022</year>
      </date>
      <date date-type="accepted">
        <day>15</day>
        <month>11</month>
        <year>2022</year>
      </date>
    </history>
    <permissions>
      <copyright-statement>© The Author(s) 2022</copyright-statement>
      <license>
        <ali:license_ref specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
        <license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link>.</license-p>
      </license>
    </permissions>
    <abstract id="Abs1">
      <p id="Par1">Cancer has become a major factor threatening human life and health. Under the circumstance that traditional treatment methods such as chemotherapy and radiotherapy are not highly specific and often cause severe side effects and toxicity, new treatment methods are urgently needed. Anticancer peptide drugs have low toxicity, stronger efficacy and specificity, and have emerged as a new type of cancer treatment drugs. However, experimental identification of anticancer peptides is time-consuming and expensive, and difficult to perform in a high-throughput manner. Computational identification of anticancer peptides can make up for the shortcomings of experimental identification. In this study, a deep learning-based predictor named ACPred-BMF is proposed for the prediction of anticancer peptides. This method uses the quantitative and qualitative properties of amino acids, binary profile feature to numerical representation for the peptide sequences. The Bidirectional LSTM network architecture is used in the model, and the attention mechanism is also considered. To alleviate the black-box problem of deep learning model prediction, we visualized the automatically extracted features and used the Shapley additive explanations algorithm to determine the importance of features to further understand the anticancer peptide mechanism. The results show that our method is one of the state-of-the-art anticancer peptide predictors. A web server as the implementation of ACPred-BMF that can be accessed via: <ext-link ext-link-type="uri" xlink:href="http://mialab.ruc.edu.cn/ACPredBMFServer/">http://mialab.ruc.edu.cn/ACPredBMFServer/</ext-link>.</p>
    </abstract>
    <kwd-group kwd-group-type="npg-subject">
      <title>Subject terms</title>
      <kwd>Computational biology and bioinformatics</kwd>
      <kwd>Computational models</kwd>
      <kwd>Machine learning</kwd>
    </kwd-group>
    <funding-group>
      <award-group>
        <funding-source>
          <institution>National Natural Science Foundation of China</institution>
        </funding-source>
        <award-id>31670725</award-id>
      </award-group>
    </funding-group>
    <custom-meta-group>
      <custom-meta>
        <meta-name>issue-copyright-statement</meta-name>
        <meta-value>© The Author(s) 2022</meta-value>
      </custom-meta>
    </custom-meta-group>
  </article-meta>
</front>
<body>
  <sec id="Sec1">
    <title>Introduction</title>
    <p id="Par2">Cancer is a major public health problem worldwide<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. According to data released by the International Agency for Research on Cancer (IARC), an agency under the WHO, there were 9.96 million cancer deaths worldwide in 2020. Deaths from cancer will continue to grow, reaching 16.3 million in 2040, according to IARC forecasts. Conventional chemotherapy, radiotherapy, and surgical treatments of cancer mainly focus on mass cell killing without high specificity and often cause severe side effects and toxicities<sup><xref ref-type="bibr" rid="CR2">2</xref>–<xref ref-type="bibr" rid="CR4">4</xref></sup>. Traditional treatments have limited efficacy and damage normal cells. Ideally, anticancer therapy should destroy a range of cancer types, but not all healthy cells<sup><xref ref-type="bibr" rid="CR5">5</xref></sup>.</p>
    <p id="Par3">Under such circumstances, it is urgent to develop new therapeutic approaches to treat cancer. Anticancer peptides (ACPs) show great potential in the treatment of cancer: they destroy cancer cells via apoptosis and necrosis and they can inhibit tumor growth through immunomodulation<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR5">5</xref></sup>. This anticancer mechanism is nonspecific for cancer types, and is general to different cancers<sup><xref ref-type="bibr" rid="CR6">6</xref></sup>. In addition, healthy cells are electrically neutral, while cancer cells contain negatively charged components on their surfaces, and their membranes are more fluid <sup><xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR8">8</xref></sup>. When the cationic ACP interacts with cancer cells, it causes destabilization and lysis of the cancer cell membrane without damaging normal cells<sup><xref ref-type="bibr" rid="CR2">2</xref>,<xref ref-type="bibr" rid="CR5">5</xref>,<xref ref-type="bibr" rid="CR9">9</xref></sup>. Compared with chemotherapy or surgery, ACPs are thought to have at least the same efficacy, but with additional advantages in terms of safety. Because chemotherapy often has serious adverse effects, surgery presents additional risks to patients<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Compared with other molecules, short peptides are less immunogenic, and more stable in vitro; at the same time, since the main products of peptide metabolism are amino acids, such drugs generally have lower toxicity features<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR10">10</xref></sup>.</p>
    <p id="Par4">ACP drugs have low toxicity, stronger efficacy and specificity for cancer cells, and have become a new type of cancer treatment drugs<sup><xref ref-type="bibr" rid="CR7">7</xref>,<xref ref-type="bibr" rid="CR11">11</xref></sup>. Rapid and accurate identification of potential ACPs in a large number of proteins is of great significance for the development of new drugs, however, identification by experimental methods is time-consuming, expensive, and difficult to apply in a high-throughput manner<sup><xref ref-type="bibr" rid="CR12">12</xref></sup>. In contrast, using computational methods can avoid the shortcomings of traditional methods and achieve high-throughput prediction of ACPs. Therefore, it is of great practical significance to study high-performance predictors of ACPs.</p>
    <p id="Par5">In recent years, much research has been done for the prediction of ACPs, and has made excellent progress. ACP prediction methods are mainly divided into traditional machine learning-based methods and deep learning-based methods. Traditional machine learning-based methods mainly rely on manually extracting features, which are obtained by converting each peptide sequence into a fixed-length numeric vector, and use classifiers such as support vector machine (SVM) and random forest (RF) for identifying ACPs. In 2013, Tyagi et al.<sup><xref ref-type="bibr" rid="CR13">13</xref></sup> first proposed a machine learning-based predictor AntiCP, which used features such as amino acid composition (AAC), dipeptide composition (DPC) and binary profile feature (BPF) as the input of the SVM classifier. In 2015, Vijayakumar et al.<sup><xref ref-type="bibr" rid="CR14">14</xref></sup> proposed the SVM-based predictor ACPP, and used protein relatedness measure which incorporates not only compositional information but also centroidal and distributional measures of amino acids. Subsequently, Chen et al.<sup><xref ref-type="bibr" rid="CR15">15</xref></sup> proposed the predictor called iACP developed by the approach of optimizing the g-gap dipeptide composition (g-gap DPC), which used the SVM classifier for prediction. In 2017, Akbar et al.<sup><xref ref-type="bibr" rid="CR16">16</xref></sup> developed an evolutionary intelligent genetic algorithm-based ensemble model called iACP-GAEnsC, in which the peptide sequences are formulated by three different features, i.e., amphiphilic pseudo amino acid composition (Am-PseAAC)<sup><xref ref-type="bibr" rid="CR17">17</xref></sup>, g-gap DPC, and Reduced amino acid alphabet composition. In the same year, Balachandran et al.<sup><xref ref-type="bibr" rid="CR18">18</xref></sup> proposed MLACP, which describes peptide sequences based on features including AAC, DPC, atomic composition, and physicochemical properties, then uses SVM and RF for prediction. It can be seen that there are many types of sequence-based feature descriptors available, and feature selection is necessary to avoid the dimensional disaster and information redundancy. In 2018, Wei et al.<sup><xref ref-type="bibr" rid="CR19">19</xref></sup> developed an ACP prediction algorithm called ACPred-FL that extracts and learns a 40-dimensional feature vector from SVM-based models trained using sequence-based feature descriptors, and further through feature selection techniques to improve the feature representation ability. Rao et al.<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> presented ACPred-Fuse that integrated a total of 29 different handcrafted features (HF) and performed feature selection on them. In 2019, Schaduangrat et al.<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> proposed a predictor called ACPred, which is based on the feature combination of AAC, DPC, physicochemical properties, pseudo-amino acid composition (PseAAC)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>, Am-PseAAC, etc., using RF and SVM as classifiers. Agrawal et al.<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> proposed the predictor called AntiCP2.0, which was developed by extremely randomized trees (ETree) algorithm with the AAC and DPC. The traditional machine learning-based methods for ACP prediction have been very mature and have produced good prediction results on some datasets. However, the methods based on traditional machine learning themselves have some inherent defects. First, the feature extraction methods transform the peptide sequence into a fixed-length feature vector, which is easy to lose some information, especially for long sequences<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. In addition, these feature extraction methods can only extract the local order of peptide sequence through features such as DPC<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, and it is difficult to grasp the global order information. Finally, the performance of these methods is largely related to manual feature extraction mechanisms, but it is not easy to extract suitable features for different data<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>.</p>
    <p id="Par6">The deep learning-based methods for ACP prediction gradually came into existence in 2017<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Yi et al.<sup><xref ref-type="bibr" rid="CR28">28</xref></sup> proposed ACP-DL in 2019, which uses BPF and k-mer sparse matrix feature to represent the peptide sequences, and uses Long Short-Term Memory Model (LSTM) for prediction. Unlike traditional machine learning-based methods, deep learning-based methods do not require manual feature extraction to represent the input data<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>, that is, they can automatically extract features<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. The methods based on deep learning can be divided into two categories: one uses deep learning methods to extract features, and then inputs the features into traditional machine learning classifiers such as SVM and RF for prediction; the other directly uses the deep learning method to make the final prediction. In the first category, Lv et al.<sup><xref ref-type="bibr" rid="CR30">30</xref></sup> proposed an ACP predictor that uses two embedding models SSA and UniRep to extract features and inputs them into 6 machine learning models such as SVM for classification, respectively. But this method is not end-to-end, and there may be some intermediate losses.</p>
    <p id="Par7">In the second category, how the sequences are represented numerically is crucial<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Wu et al.<sup><xref ref-type="bibr" rid="CR31">31</xref></sup> adopted the word2vec word embedding method to encode sequences. The Word2vec<sup><xref ref-type="bibr" rid="CR32">32</xref>,<xref ref-type="bibr" rid="CR33">33</xref></sup> method learns word embedding using shallow neural networks and is widely used in natural language processing. He et al.<sup><xref ref-type="bibr" rid="CR27">27</xref></sup> proposed a deep learning-based predictor called ACPred-LAF, to encode sequences with a multisense-scaled embedding algorithm. These embedding methods can effectively describe the peptide sequence and retain the original information of the data, but it does not apply the prior biological information of amino acids in the numerical representation for the peptide sequences, and lacks biological interpretability to some extent. After the embedding layer, they used the encoder structure in the transformer<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> to predict ACPs, which requires many hyperparameters to be adjusted, including the number of self-attention heads, the dimensions of query, key, and value ,etc. In 2021, Ahmed et al.<sup><xref ref-type="bibr" rid="CR26">26</xref></sup> developed ACP-MHCNN based on a multi-head convolutional neural network, which uses BPF, physicochemical properties of amino acids, sequence evolution information to numerically represent peptide sequences. This numerical representation method integrates multiple aspects of information and has biological significance. However, only 15 N-terminal residues of the peptide sequence are used in this method. For sequences of length greater than 15, sequence information is lost during numeralization. Given the lack of biological interpretability and loss of sequence information in existing numerical representation methods, we considered using a variety of amino acid features to numerically represent peptide sequences to make full use of the information in peptide sequences and at the same time considered the biological meaning of the numerical representation.</p>
    <p id="Par8">In this paper, we developed a new deep learning-based ACP predictor named ACPred-BMF, which is based on a peptide sequence representation method and a Bidirectional LSTM neural network framework. By integrating BPF, qualitative and quantitative properties of amino acids into one vector to numerically represent residues, we obtained a new numerical representation for peptide sequences, which contains sequence information and prior information to more comprehensively characterize the peptide sequence. Considering the structure nature of RNN recurrent connections, we used Bidirectional LSTM neural network framework to learn the order information contained in the sequences, which is difficult for traditional machine learning-based methods. We first conducted explainable prediction among deep learning-based methods for ACP prediction by using a Shapley additive explanations (SHAP) algorithm to interpret the model and obtain relatively important features for ACP prediction. Comparative experiments show that ACPred-BMF is one of the state-of-the-art predictors compared to the existing ACP prediction methods.</p>
  </sec>
  <sec id="Sec2">
    <title>Materials and methods</title>
    <sec id="Sec3">
      <title>Benchmark dataset</title>
      <p id="Par9">In this study, we used the benchmark datasets collected by Agrawal et al. in AntiCP2.0<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> for model training and result comparisons. The benchmark datasets could be downloaded from <ext-link ext-link-type="uri" xlink:href="https://webs.iiitd.edu.in/raghava/anticp2/download.php">https://webs.iiitd.edu.in/raghava/anticp2/download.php</ext-link>. It consisted of the main dataset and the alternate dataset.<disp-quote><p id="Par10">(i) In the main dataset, ACPs verified in the experiment were taken as positive samples, and anti-microbial peptides (AMPs) were taken as non-ACPs, i.e., negative samples. It contains 1722 peptides of which 861 ACPs and 861 non-ACPs (or AMPs).</p><p id="Par11">(ii) In the alternate dataset, ACPs and random peptides were regarded as positive samples and negative samples, respectively. It contains 1940 peptides, including 970 experimentally validated ACPs and 970 random peptides.</p></disp-quote></p>
    </sec>
    <sec id="Sec4">
      <title>Five-fold cross-validation and independent testing</title>
      <p id="Par12">K-fold cross-validation and independent testing are common methods to evaluate the quality of machine learning models. K-fold cross-validation divides the training set into K parts, and each part consisted of an equal number of positive samples and negative samples. Any K-1 parts are used for training and the other part is used as a validation set. Finally, the results of K models on their respective validation sets are averaged to obtain the K-fold cross-validation performance. The current research conducted the fivefold (<italic>K</italic> = 5) cross-validation.</p>
      <p id="Par13">For a fair comparison, we adopted the datasets used by Agrawal et al.<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>, in which each dataset was divided into a training dataset and an independent testing dataset in a ratio of 8:2. We conducted five-fold cross-validation on the training dataset to select the optimal parameters. Further, the model trained on the whole training dataset was used to predict the independent testing dataset, so as to obtain the performance of the model on the independent test dataset, which is the independent testing process.</p>
    </sec>
    <sec id="Sec5">
      <title>Numerical representation for peptide sequences</title>
      <p id="Par14">In the original data, the peptide sequence is a character sequence consisting of 20 amino acid characters, such as a peptide sequence <inline-formula id="IEq1"><alternatives><tex-math id="M1">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$P$$\end{document}</tex-math><mml:math id="M2"><mml:mi>P</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq1.gif"/></alternatives></inline-formula>,<disp-formula id="Equ1"><label>1</label><alternatives><tex-math id="M3">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {P = p_{1} p_{2} p_{3} \ldots p_{L}  } \\ \end{array} $$\end{document}</tex-math><mml:math id="M4" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>P</mml:mi><mml:mo>=</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mn>1</mml:mn></mml:msub><mml:msub><mml:mi>p</mml:mi><mml:mn>2</mml:mn></mml:msub><mml:msub><mml:mi>p</mml:mi><mml:mn>3</mml:mn></mml:msub><mml:mo>…</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>L</mml:mi></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ1.gif" position="anchor"/></alternatives></disp-formula></p>
      <p id="Par15">where <inline-formula id="IEq2"><alternatives><tex-math id="M5">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{i}$$\end{document}</tex-math><mml:math id="M6"><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq2.gif"/></alternatives></inline-formula> represents the <inline-formula id="IEq3"><alternatives><tex-math id="M7">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i$$\end{document}</tex-math><mml:math id="M8"><mml:mi>i</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq3.gif"/></alternatives></inline-formula>-th residue in the peptide sequence, <inline-formula id="IEq4"><alternatives><tex-math id="M9">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i = 1,2, \ldots ,L$$\end{document}</tex-math><mml:math id="M10"><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mi>L</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq4.gif"/></alternatives></inline-formula>;<inline-formula id="IEq5"><alternatives><tex-math id="M11">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$${ }p_{i} \in \left\{ {A,{ }C,{ }D,{ }E,{ }F,{ }G,{ }H,{ }I,{ }K,L,M,N,P,Q,R,S,T,V,W,Y} \right\}$$\end{document}</tex-math><mml:math id="M12"><mml:mrow><mml:mrow/><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:mfenced close="}" open="{"><mml:mrow><mml:mi>A</mml:mi><mml:mo>,</mml:mo><mml:mrow/><mml:mi>C</mml:mi><mml:mo>,</mml:mo><mml:mrow/><mml:mi>D</mml:mi><mml:mo>,</mml:mo><mml:mrow/><mml:mi>E</mml:mi><mml:mo>,</mml:mo><mml:mrow/><mml:mi>F</mml:mi><mml:mo>,</mml:mo><mml:mrow/><mml:mi>G</mml:mi><mml:mo>,</mml:mo><mml:mrow/><mml:mi>H</mml:mi><mml:mo>,</mml:mo><mml:mrow/><mml:mi>I</mml:mi><mml:mo>,</mml:mo><mml:mrow/><mml:mi>K</mml:mi><mml:mo>,</mml:mo><mml:mi>L</mml:mi><mml:mo>,</mml:mo><mml:mi>M</mml:mi><mml:mo>,</mml:mo><mml:mi>N</mml:mi><mml:mo>,</mml:mo><mml:mi>P</mml:mi><mml:mo>,</mml:mo><mml:mi>Q</mml:mi><mml:mo>,</mml:mo><mml:mi>R</mml:mi><mml:mo>,</mml:mo><mml:mi>S</mml:mi><mml:mo>,</mml:mo><mml:mi>T</mml:mi><mml:mo>,</mml:mo><mml:mi>V</mml:mi><mml:mo>,</mml:mo><mml:mi>W</mml:mi><mml:mo>,</mml:mo><mml:mi>Y</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq5.gif"/></alternatives></inline-formula>; <inline-formula id="IEq6"><alternatives><tex-math id="M13">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$L$$\end{document}</tex-math><mml:math id="M14"><mml:mi>L</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq6.gif"/></alternatives></inline-formula> represents the length of the peptide sequence <inline-formula id="IEq7"><alternatives><tex-math id="M15">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$P.$$\end{document}</tex-math><mml:math id="M16"><mml:mrow><mml:mi>P</mml:mi><mml:mo>.</mml:mo></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq7.gif"/></alternatives></inline-formula> These peptide sequences vary in length, ranging from 3 to 50. The input of the deep learning model should be in the form of a numerical vector instead of a character sequence, so a numerical representation for the original data is required.</p>
      <p id="Par16">From the two perspectives of keeping the original information of the sequences as much as possible and utilizing the prior knowledge in biology, this study considered the following features to represent the sequence numerically.</p>
      <sec id="Sec6">
        <title>Binary profile feature (BPF)</title>
        <p id="Par17">This feature encodes each of the 20 amino acids (A, C, D, E, F, G, H, I, K, L, M, N, P, Q, R, S, T, V, W and Y) into a 20-dimensional 0–1 vector. Specifically, A is represented as (1,0, … ,0), C is represented as (0,1, …, 0), Y is represented as (0,0, …, 1) and so on. This feature has been widely used in ACP prediction and contributes to the improvement of prediction performance<sup><xref ref-type="bibr" rid="CR13">13</xref>,<xref ref-type="bibr" rid="CR21">21</xref>,<xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR28">28</xref></sup>.</p>
      </sec>
      <sec id="Sec7">
        <title>Quantitative properties of amino acids (Quanc)</title>
        <p id="Par18">Amino acids have some quantitative properties, such as molecular weight, isoelectric point, etc. However, as far as we know, the quantitative properties of amino acids rarely have been directly applied to ACP prediction. These properties can describe the differences between amino acids from multiple perspectives, and this description has practical biological significance. The quantitative properties of amino acids used here are shown in Table <xref rid="Tab1" ref-type="table">1</xref>.<table-wrap id="Tab1"><label>Table 1</label><caption><p>Quantitative properties of amino acids.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Amino acid</th><th align="left">Molecular mass<sup><xref ref-type="bibr" rid="CR35">35</xref>,<xref ref-type="bibr" rid="CR36">36</xref></sup></th><th align="left">isoelectric point<sup><xref ref-type="bibr" rid="CR37">37</xref></sup></th><th align="left">pk1<sup><xref ref-type="bibr" rid="CR38">38</xref></sup></th><th align="left">pk2<sup><xref ref-type="bibr" rid="CR38">38</xref></sup></th><th align="left">pKa<sup><xref ref-type="bibr" rid="CR38">38</xref></sup></th><th align="left">van der Waals volumes<sup><xref ref-type="bibr" rid="CR39">39</xref></sup></th></tr></thead><tbody><tr><td align="left">G</td><td char="." align="char">75.07</td><td char="." align="char">6.06</td><td char="." align="char">2.34</td><td char="." align="char">9.6</td><td align="left">0</td><td align="left">47.3</td></tr><tr><td align="left">A</td><td char="." align="char">89.09</td><td char="." align="char">6.11</td><td char="." align="char">2.34</td><td char="." align="char">9.69</td><td align="left">0</td><td align="left">64.4</td></tr><tr><td align="left">V</td><td char="." align="char">117.15</td><td char="." align="char">6.02</td><td char="." align="char">2.32</td><td char="." align="char">9.62</td><td align="left">0</td><td align="left">98.6</td></tr><tr><td align="left">L</td><td char="." align="char">131.17</td><td char="." align="char">6.04</td><td char="." align="char">2.36</td><td char="." align="char">9.6</td><td align="left">0</td><td align="left">115.7</td></tr><tr><td align="left">I</td><td char="." align="char">131.17</td><td char="." align="char">6.04</td><td char="." align="char">2.36</td><td char="." align="char">9.6</td><td align="left">0</td><td align="left">115.7</td></tr><tr><td align="left">F</td><td char="." align="char">165.19</td><td char="." align="char">5.76</td><td char="." align="char">1.83</td><td char="." align="char">9.13</td><td align="left">0</td><td align="left">139.9</td></tr><tr><td align="left">W</td><td char="." align="char">204.23</td><td char="." align="char">5.88</td><td char="." align="char">2.83</td><td char="." align="char">9.39</td><td align="left">0</td><td align="left">196.9</td></tr><tr><td align="left">Y</td><td char="." align="char">181.19</td><td char="." align="char">5.63</td><td char="." align="char">2.2</td><td char="." align="char">9.11</td><td align="left">10.07</td><td align="left">136.9</td></tr><tr><td align="left">D</td><td char="." align="char">133.1</td><td char="." align="char">2.98</td><td char="." align="char">1.88</td><td char="." align="char">9.6</td><td align="left">3.65</td><td align="left">80.1</td></tr><tr><td align="left">H</td><td char="." align="char">155.16</td><td char="." align="char">7.64</td><td char="." align="char">1.82</td><td char="." align="char">9.17</td><td align="left">6</td><td align="left">118.9</td></tr><tr><td align="left">N</td><td char="." align="char">132.12</td><td char="." align="char">5.43</td><td char="." align="char">2.02</td><td char="." align="char">8.8</td><td align="left">0</td><td align="left">94.6</td></tr><tr><td align="left">E</td><td char="." align="char">147.13</td><td char="." align="char">3.08</td><td char="." align="char">2.19</td><td char="." align="char">9.67</td><td align="left">4.25</td><td align="left">97.2</td></tr><tr><td align="left">K</td><td char="." align="char">146.19</td><td char="." align="char">9.47</td><td char="." align="char">2.18</td><td char="." align="char">8.95</td><td align="left">10.53</td><td align="left">118.1</td></tr><tr><td align="left">Q</td><td char="." align="char">146.15</td><td char="." align="char">5.65</td><td char="." align="char">2.17</td><td char="." align="char">9.13</td><td align="left">0</td><td align="left">111.7</td></tr><tr><td align="left">M</td><td char="." align="char">149.21</td><td char="." align="char">5.71</td><td char="." align="char">2.28</td><td char="." align="char">9.21</td><td align="left">0</td><td align="left">120.5</td></tr><tr><td align="left">R</td><td char="." align="char">174.2</td><td char="." align="char">10.76</td><td char="." align="char">2.17</td><td char="." align="char">9.04</td><td align="left">12.48</td><td align="left">138.4</td></tr><tr><td align="left">S</td><td char="." align="char">105.09</td><td char="." align="char">5.7</td><td char="." align="char">2.21</td><td char="." align="char">9.15</td><td align="left">0</td><td align="left">66.1</td></tr><tr><td align="left">T</td><td char="." align="char">119.12</td><td char="." align="char">5.6</td><td char="." align="char">2.09</td><td char="." align="char">9.1</td><td align="left">0</td><td align="left">88.9</td></tr><tr><td align="left">C</td><td char="." align="char">121.16</td><td char="." align="char">5.15</td><td char="." align="char">1.96</td><td char="." align="char">10.28</td><td align="left">8.18</td><td align="left">82.2</td></tr><tr><td align="left">P</td><td char="." align="char">115.13</td><td char="." align="char">6.3</td><td char="." align="char">1.99</td><td char="." align="char">10.6</td><td align="left">0</td><td align="left">88</td></tr></tbody></table><table-wrap-foot><p>In this table, <italic>p</italic>
<inline-formula id="IEq70"><alternatives><tex-math id="M17">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$K_{a}$$\end{document}</tex-math><mml:math id="M18"><mml:msub><mml:mi>K</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq70.gif"/></alternatives></inline-formula> = 0 is the padding data.</p></table-wrap-foot></table-wrap></p>
        <p id="Par19">There are different orders of magnitude between different attributes (columns) in Table <xref rid="Tab1" ref-type="table">1</xref>, and the data needs to be standardized to make properties with different measures comparable. Perform <inline-formula id="IEq8"><alternatives><tex-math id="M19">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ z - score$$\end{document}</tex-math><mml:math id="M20"><mml:mrow><mml:mi>z</mml:mi><mml:mo>-</mml:mo><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>o</mml:mi><mml:mi>r</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq8.gif"/></alternatives></inline-formula> standardization on the data in Table <xref rid="Tab1" ref-type="table">1</xref>, set that the <inline-formula id="IEq9"><alternatives><tex-math id="M21">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i$$\end{document}</tex-math><mml:math id="M22"><mml:mi>i</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq9.gif"/></alternatives></inline-formula>-th row and the <inline-formula id="IEq10"><alternatives><tex-math id="M23">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$j$$\end{document}</tex-math><mml:math id="M24"><mml:mi>j</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq10.gif"/></alternatives></inline-formula>-th column of the original data and standardized data in Table <xref rid="Tab1" ref-type="table">1</xref> are <inline-formula id="IEq11"><alternatives><tex-math id="M25">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$x_{ij}$$\end{document}</tex-math><mml:math id="M26"><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq11.gif"/></alternatives></inline-formula> and <inline-formula id="IEq12"><alternatives><tex-math id="M27">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$z_{ij} \left( {i = 1,2, \ldots ,20;j = 1,2, \ldots ,6} \right)$$\end{document}</tex-math><mml:math id="M28"><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mfenced close=")" open="("><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mn>20</mml:mn><mml:mo>;</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:mn>6</mml:mn></mml:mrow></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq12.gif"/></alternatives></inline-formula> respectively. The calculation process of <inline-formula id="IEq13"><alternatives><tex-math id="M29">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$z_{ij}$$\end{document}</tex-math><mml:math id="M30"><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq13.gif"/></alternatives></inline-formula> is as follows:<disp-formula id="Equ2"><label>2</label><alternatives><tex-math id="M31">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {z_{ij} = \frac{{(x_{ij} - \mu_{j} ){ }}}{{\sigma_{j} }}  } \\ \end{array} $$\end{document}</tex-math><mml:math id="M32" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>z</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo stretchy="false">(</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo stretchy="false">)</mml:mo><mml:mrow/></mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ2.gif" position="anchor"/></alternatives></disp-formula>
where<disp-formula id="Equ3"><label>3</label><alternatives><tex-math id="M33">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {\mu_{j} = \frac{{\mathop \sum \nolimits_{i = 1}^{20} x_{ij} }}{20} } \\ \end{array} $$\end{document}</tex-math><mml:math id="M34" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>μ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:msubsup><mml:mo>∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mn>20</mml:mn></mml:msubsup><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:mrow><mml:mn>20</mml:mn></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ3.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ4"><label>4</label><alternatives><tex-math id="M35">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {\sigma_{j} = \sqrt {\frac{1}{20}\mathop \sum \limits_{i = 1}^{20} \left( {x_{ij} - \mu_{j} } \right)^{2} }  } \\ \end{array} $$\end{document}</tex-math><mml:math id="M36" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>σ</mml:mi><mml:mi>j</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msqrt><mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mn>20</mml:mn></mml:mfrac><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mn>20</mml:mn></mml:munderover><mml:msup><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>-</mml:mo><mml:msub><mml:mi>μ</mml:mi><mml:mi>j</mml:mi></mml:msub></mml:mrow></mml:mfenced><mml:mn>2</mml:mn></mml:msup></mml:mrow></mml:msqrt></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ4.gif" position="anchor"/></alternatives></disp-formula></p>
      </sec>
      <sec id="Sec8">
        <title>Qualitative properties of amino acids (Qualc)</title>
        <p id="Par21">Besides quantitative properties, amino acids have some qualitative physicochemical properties such as hydrophobicity, polarity, etc. In previous studies of traditional machine learning-based methods<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR21">21</xref></sup>, the qualitative physicochemical properties of amino acids have also been exploited and have been shown to help improve the performance of the predictor. We represented amino acids based on their qualitative properties <sup><xref ref-type="bibr" rid="CR40">40</xref></sup>, such that under a certain property (such as charged), amino acids with the same class have the same representation. Based on this consideration, the qualitative properties of amino acids (Qualc) are proposed in this paper, which are shown in Table <xref rid="Tab2" ref-type="table">2</xref>.<table-wrap id="Tab2"><label>Table 2</label><caption><p>Qualitative properties of amino acids.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Qualitative Properties</th><th align="left">Category</th><th align="left">Amino acid</th></tr></thead><tbody><tr><td align="left" rowspan="2">hydrophobicity<sup><xref ref-type="bibr" rid="CR40">40</xref></sup></td><td align="left">Y</td><td align="left">G, A, V, L, I, F, W, Y, H, K, M, T, C</td></tr><tr><td align="left">N</td><td align="left">D, N, E, Q, R, S, P</td></tr><tr><td align="left" rowspan="2">polarity<sup><xref ref-type="bibr" rid="CR40">40</xref></sup></td><td align="left">Y</td><td align="left">W, Y, D, H, N, E, K, Q, R, S, T, C</td></tr><tr><td align="left">N</td><td align="left">G, A, V, L, I, F, M, P</td></tr><tr><td align="left" rowspan="3">charge<sup><xref ref-type="bibr" rid="CR40">40</xref></sup></td><td align="left">Negative</td><td align="left">D, E</td></tr><tr><td align="left">Positive</td><td align="left">H, K, R</td></tr><tr><td align="left">N</td><td align="left">G, A, V, L, I, F, W, Y, N, Q, M, S, T, C, P</td></tr><tr><td align="left" rowspan="3">Aromatic or aliphatic<sup>41</sup></td><td align="left">Aromatic</td><td align="left">F, W, Y, H</td></tr><tr><td align="left">Aliphatic</td><td align="left">L, I, V</td></tr><tr><td align="left">N</td><td align="left">G, A, D, N, E, K, Q, M, R, S, T, C, P</td></tr></tbody></table><table-wrap-foot><p>In this table, ‘Y’ and ‘N’ indicate amino acid categories with and without the corresponding property (in the first column).</p></table-wrap-foot></table-wrap></p>
        <p id="Par22">Since the physicochemical properties of the amino acids described in Table <xref rid="Tab2" ref-type="table">2</xref> are in the form of characters, they cannot be directly used to represent the peptide sequence numerically. So, the raw data in Table <xref rid="Tab2" ref-type="table">2</xref> needs to be one-hot encoded to convert character data to numeric data, i.e. set <inline-formula id="IEq14"><alternatives><tex-math id="M37">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n $$\end{document}</tex-math><mml:math id="M38"><mml:mi>n</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq14.gif"/></alternatives></inline-formula> variables for the <inline-formula id="IEq15"><alternatives><tex-math id="M39">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n$$\end{document}</tex-math><mml:math id="M40"><mml:mi>n</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq15.gif"/></alternatives></inline-formula> categories of each property, if the amino acid belongs to the category corresponding to the variable under this property, the variable value is 1, otherwise, it is 0. For example, for charge, set three variables "charge_positive", “charge_negative”, "charge_N", for the amino acid <inline-formula id="IEq16"><alternatives><tex-math id="M41">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$p_{i}$$\end{document}</tex-math><mml:math id="M42"><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq16.gif"/></alternatives></inline-formula>, there are:<disp-formula id="Equ5"><label>5</label><alternatives><tex-math id="M43">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {charge\_positive\left( {p_{i} } \right) = \left\{ {\begin{array}{*{20}c} {1,p_{i} is positive} \\ {0,p_{i} is not positive} \\ \end{array} } \right. } \\ \end{array} $$\end{document}</tex-math><mml:math id="M44" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>_</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced open="{"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>p</mml:mi><mml:mi>o</mml:mi><mml:mi>s</mml:mi><mml:mi>i</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ5.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ6"><label>6</label><alternatives><tex-math id="M45">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {charge\_negative\left( {p_{i} } \right) = \left\{ {\begin{array}{*{20}c} {1,p_{i} is negative} \\ {0,p_{i} is not negative} \\ \end{array} } \right. } \\ \end{array} $$\end{document}</tex-math><mml:math id="M46" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>_</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced open="{"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>n</mml:mi><mml:mi>e</mml:mi><mml:mi>g</mml:mi><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>i</mml:mi><mml:mi>v</mml:mi><mml:mi>e</mml:mi></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ6.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ7"><label>7</label><alternatives><tex-math id="M47">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {charge\_N\left( {p_{i} } \right) = \left\{ {\begin{array}{*{20}c} {1,p_{i} is not charged} \\ {0,p_{i} is charged} \\ \end{array} } \right. } \\ \end{array} $$\end{document}</tex-math><mml:math id="M48" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>_</mml:mi><mml:mi>N</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:mfenced open="{"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>n</mml:mi><mml:mi>o</mml:mi><mml:mi>t</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:mtd></mml:mtr><mml:mtr><mml:mtd><mml:mrow><mml:mrow/><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:msub><mml:mi>p</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>i</mml:mi><mml:mi>s</mml:mi><mml:mi>c</mml:mi><mml:mi>h</mml:mi><mml:mi>a</mml:mi><mml:mi>r</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mi>d</mml:mi></mml:mrow></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ7.gif" position="anchor"/></alternatives></disp-formula></p>
      </sec>
      <sec id="Sec9">
        <title>Feature combinations</title>
        <p id="Par23">The three features proposed above describe 20 amino acids from different perspectives, and we considered the use of feature combinations for numerical representation. Since each vector encoded by BPF has a one-to-one correspondence with amino acids, which is an essential feature, BPF representation is used in each feature combination. We considered the 4 feature combinations listed in Table <xref rid="Tab3" ref-type="table">3</xref>.<table-wrap id="Tab3"><label>Table 3</label><caption><p>Feature combinations and their coding dimensions.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Feature combination</th><th align="left">Coding dimension of single residue</th></tr></thead><tbody><tr><td align="left">BPF(bpf)</td><td align="left">20</td></tr><tr><td align="left">BPF + Quanc (quanc)</td><td align="left">26</td></tr><tr><td align="left">BPF + Qualc (quanl)</td><td align="left">30</td></tr><tr><td align="left">BPF + Quanc + Qualc (mix)</td><td align="left">36</td></tr></tbody></table><table-wrap-foot><p>In the first column, the content in parentheses represents the abbreviation of the feature combination.</p></table-wrap-foot></table-wrap></p>
        <p id="Par24">Let the numerical representation dimension of each residue be <inline-formula id="IEq17"><alternatives><tex-math id="M49">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d$$\end{document}</tex-math><mml:math id="M50"><mml:mi>d</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq17.gif"/></alternatives></inline-formula> (<inline-formula id="IEq18"><alternatives><tex-math id="M51">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d$$\end{document}</tex-math><mml:math id="M52"><mml:mi>d</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq18.gif"/></alternatives></inline-formula> may be 20, 26, 30 or 36). For a sequence of length <inline-formula id="IEq19"><alternatives><tex-math id="M53">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l$$\end{document}</tex-math><mml:math id="M54"><mml:mi>l</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq19.gif"/></alternatives></inline-formula>, encode it into a <inline-formula id="IEq20"><alternatives><tex-math id="M55">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$L_{max} \times d$$\end{document}</tex-math><mml:math id="M56"><mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi mathvariant="italic">max</mml:mi></mml:mrow></mml:msub><mml:mo>×</mml:mo><mml:mi>d</mml:mi></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq20.gif"/></alternatives></inline-formula>-dimensional matrix: the first <inline-formula id="IEq21"><alternatives><tex-math id="M57">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$l$$\end{document}</tex-math><mml:math id="M58"><mml:mi>l</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq21.gif"/></alternatives></inline-formula> rows are the numerical representation of the peptide sequence; for the <inline-formula id="IEq22"><alternatives><tex-math id="M59">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\left( {l + 1} \right)$$\end{document}</tex-math><mml:math id="M60"><mml:mfenced close=")" open="("><mml:mrow><mml:mi>l</mml:mi><mml:mo>+</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq22.gif"/></alternatives></inline-formula>-th row to <inline-formula id="IEq23"><alternatives><tex-math id="M61">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$L_{max}$$\end{document}</tex-math><mml:math id="M62"><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi mathvariant="italic">max</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq23.gif"/></alternatives></inline-formula>-th row, the same value is used for the padding operation. <inline-formula id="IEq24"><alternatives><tex-math id="M63">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$L_{{{\text{max}}}}$$\end{document}</tex-math><mml:math id="M64"><mml:msub><mml:mi>L</mml:mi><mml:mtext>max</mml:mtext></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq24.gif"/></alternatives></inline-formula> is the longest sequence length in the data, in this paper <inline-formula id="IEq25"><alternatives><tex-math id="M65">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$L_{{{\text{max}}}} = 50$$\end{document}</tex-math><mml:math id="M66"><mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mtext>max</mml:mtext></mml:msub><mml:mo>=</mml:mo><mml:mn>50</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq25.gif"/></alternatives></inline-formula>.</p>
      </sec>
    </sec>
    <sec id="Sec10">
      <title>Deep learning methods</title>
      <sec id="Sec11">
        <title>Recurrent neural network (RNN)</title>
        <p id="Par25">The core idea of the recurrent neural network<sup><xref ref-type="bibr" rid="CR41">41</xref>,<xref ref-type="bibr" rid="CR42">42</xref></sup> is to transfer the historical information to the current moment, and use it together with the input of the current moment to generate the output of the current moment. In this way, the model has a memory along time, that is, it can retain the order information of the data, which is suitable for processing sequence data such as peptide sequences. The recurrent neural network updates the hidden state at time <inline-formula id="IEq26"><alternatives><tex-math id="M67">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$t$$\end{document}</tex-math><mml:math id="M68"><mml:mi>t</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq26.gif"/></alternatives></inline-formula> by the Eq. (<xref rid="Equ8" ref-type="">8</xref>):<disp-formula id="Equ8"><label>8</label><alternatives><tex-math id="M69">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {h_{t} = f\left( {h_{t - 1} ,x_{t} } \right) } \\ \end{array} $$\end{document}</tex-math><mml:math id="M70" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>f</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>-</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:msub><mml:mo>,</mml:mo><mml:msub><mml:mi>x</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ8.gif" position="anchor"/></alternatives></disp-formula></p>
        <p id="Par26">where <inline-formula id="IEq27"><alternatives><tex-math id="M71">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$h_{0} = 0$$\end{document}</tex-math><mml:math id="M72"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>0</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq27.gif"/></alternatives></inline-formula>; <inline-formula id="IEq28"><alternatives><tex-math id="M73">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$h_{t}$$\end{document}</tex-math><mml:math id="M74"><mml:msub><mml:mi>h</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq28.gif"/></alternatives></inline-formula> represents the hidden state at time <inline-formula id="IEq29"><alternatives><tex-math id="M75">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$t$$\end{document}</tex-math><mml:math id="M76"><mml:mi>t</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq29.gif"/></alternatives></inline-formula>; <inline-formula id="IEq30"><alternatives><tex-math id="M77">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$x_{t}$$\end{document}</tex-math><mml:math id="M78"><mml:msub><mml:mi>x</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq30.gif"/></alternatives></inline-formula> represents the input at time <inline-formula id="IEq31"><alternatives><tex-math id="M79">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$t$$\end{document}</tex-math><mml:math id="M80"><mml:mi>t</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq31.gif"/></alternatives></inline-formula>; <inline-formula id="IEq32"><alternatives><tex-math id="M81">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$f\left( \cdot \right)$$\end{document}</tex-math><mml:math id="M82"><mml:mrow><mml:mi>f</mml:mi><mml:mfenced close=")" open="("><mml:mo>·</mml:mo></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq32.gif"/></alternatives></inline-formula> is a nonlinear function.</p>
        <p id="Par27">In actual operation, the performance of RNN is not ideal, especially when dealing with long sequences. Hochreiter<sup><xref ref-type="bibr" rid="CR43">43</xref></sup> theoretically explained the reason why RNN is difficult to deal with long-distance dependencies and innovatively proposed a new network architecture Long-Short Term Memory(LSTM) to remedy it. As a variant of RNN, LSTM<sup><xref ref-type="bibr" rid="CR43">43</xref>,<xref ref-type="bibr" rid="CR44">44</xref></sup> often works better in experiments, so we used the LSTM model.</p>
      </sec>
      <sec id="Sec12">
        <title>Bidirectional recurrent neural network</title>
        <p id="Par28">Schuster et al.<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> proposed a bidirectional RNN, that is, a hidden layer is established through the original sequence, and then a hidden layer is established with the original sequence in reverse order, and the generated two hidden layer sequences are aggregated to obtain the final output result. This bidirectional idea is easy to generalize to variants of RNNs, such as Bidirectional LSTM (Bi-LSTM), Bidirectional GRU<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>, etc. We used a Bi-LSTM based on the following considerations: For a residue in a peptide sequence, not only the following residues have an effect on it, but also the preceding residues.</p>
      </sec>
      <sec id="Sec13">
        <title>Attention mechanism</title>
        <p id="Par29">Attention is a complex cognitive function that is essential for humans<sup><xref ref-type="bibr" rid="CR47">47</xref>–<xref ref-type="bibr" rid="CR49">49</xref></sup>. When visually perceiving things, humans typically do not see the entire scene from start to finish, but instead observe and focus on specific parts and ignore others<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Based on this visual mechanism, the attention mechanism was proposed.</p>
        <sec id="Sec14">
          <title>Attention layer</title>
          <p id="Par30">In a peptide sequence, the information contained in it is not equally important. Gautam et al.<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> demonstrated that there may be specific amino acids at the N-terminal and C-terminal positions of the peptide sequence. In order to focus the model on the N- and C-terminal information of the peptide sequences, we used the attention mechanism. For the concrete method, we referred to the attention mechanism realization of Zhou et al.<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>, which was applied in the task of relation classification.</p>
          <p id="Par31">Suppose the output of the <inline-formula id="IEq33"><alternatives><tex-math id="M83">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i$$\end{document}</tex-math><mml:math id="M84"><mml:mi>i</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq33.gif"/></alternatives></inline-formula>-th sequence passes through a Self-attention layer is <inline-formula id="IEq34"><alternatives><tex-math id="M85">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$h_{i}$$\end{document}</tex-math><mml:math id="M86"><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq34.gif"/></alternatives></inline-formula>, the trainable parameters <inline-formula id="IEq35"><alternatives><tex-math id="M87">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$W \in {\mathbb{R}}^{2n} , b \in {\mathbb{R}}^{{L_{max} }}$$\end{document}</tex-math><mml:math id="M88"><mml:mrow><mml:mi>W</mml:mi><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>n</mml:mi></mml:mrow></mml:msup><mml:mo>,</mml:mo><mml:mi>b</mml:mi><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi mathvariant="italic">max</mml:mi></mml:mrow></mml:msub></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq35.gif"/></alternatives></inline-formula>. The mathematical description of attention is as follows:<disp-formula id="Equ9"><label>9</label><alternatives><tex-math id="M89">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {e_{i} = h_{i} W + b } \\ \end{array} $$\end{document}</tex-math><mml:math id="M90" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>e</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mi>W</mml:mi><mml:mo>+</mml:mo><mml:mi>b</mml:mi></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ9.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ10"><label>10</label><alternatives><tex-math id="M91">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {\alpha_{ij} = \frac{{\exp \left( {e_{ij} } \right)}}{{\mathop \sum \nolimits_{k} \exp \left( {e_{ik} } \right) }},j = 1,2, \ldots ,L_{max}  } \\ \end{array} $$\end{document}</tex-math><mml:math id="M92" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mo>exp</mml:mo><mml:mfenced close=")" open="("><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow><mml:mrow><mml:msub><mml:mo>∑</mml:mo><mml:mi>k</mml:mi></mml:msub><mml:mo>exp</mml:mo><mml:mfenced close=")" open="("><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant="italic">ik</mml:mi></mml:mrow></mml:msub></mml:mfenced></mml:mrow></mml:mfrac><mml:mo>,</mml:mo><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn><mml:mo>,</mml:mo><mml:mn>2</mml:mn><mml:mo>,</mml:mo><mml:mo>…</mml:mo><mml:mo>,</mml:mo><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi mathvariant="italic">max</mml:mi></mml:mrow></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ10.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ11"><label>11</label><alternatives><tex-math id="M93">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {att\left( {h_{i} } \right) = \mathop \sum \limits_{j = 1}^{{L_{max} }} \alpha_{ij} h_{ij} . } \\ \end{array} $$\end{document}</tex-math><mml:math id="M94" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>t</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced><mml:mo>=</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>j</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi mathvariant="italic">max</mml:mi></mml:mrow></mml:msub></mml:munderover><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub><mml:mo>.</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ11.gif" position="anchor"/></alternatives></disp-formula>
where <inline-formula id="IEq36"><alternatives><tex-math id="M95">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$h_{i} \in {\mathbb{R}}^{{L_{{{\text{max}}}} \times 2n}}$$\end{document}</tex-math><mml:math id="M96"><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mtext>max</mml:mtext></mml:msub><mml:mo>×</mml:mo><mml:mn>2</mml:mn><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq36.gif"/></alternatives></inline-formula>, <inline-formula id="IEq37"><alternatives><tex-math id="M97">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$e_{i} \in {\mathbb{R}}^{{L_{max} }}$$\end{document}</tex-math><mml:math id="M98"><mml:mrow><mml:msub><mml:mi>e</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi mathvariant="italic">max</mml:mi></mml:mrow></mml:msub></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq37.gif"/></alternatives></inline-formula>. Let the <inline-formula id="IEq38"><alternatives><tex-math id="M99">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$j$$\end{document}</tex-math><mml:math id="M100"><mml:mi>j</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq38.gif"/></alternatives></inline-formula>-th row of <inline-formula id="IEq39"><alternatives><tex-math id="M101">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$h_{i}$$\end{document}</tex-math><mml:math id="M102"><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq39.gif"/></alternatives></inline-formula> and the <inline-formula id="IEq40"><alternatives><tex-math id="M103">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$j$$\end{document}</tex-math><mml:math id="M104"><mml:mi>j</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq40.gif"/></alternatives></inline-formula>-th element of <inline-formula id="IEq41"><alternatives><tex-math id="M105">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$e_{i}$$\end{document}</tex-math><mml:math id="M106"><mml:msub><mml:mi>e</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq41.gif"/></alternatives></inline-formula> be <inline-formula id="IEq42"><alternatives><tex-math id="M107">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ h_{ij}$$\end{document}</tex-math><mml:math id="M108"><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq42.gif"/></alternatives></inline-formula> and <inline-formula id="IEq43"><alternatives><tex-math id="M109">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$e_{ij}$$\end{document}</tex-math><mml:math id="M110"><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq43.gif"/></alternatives></inline-formula> respectively. Then for the <inline-formula id="IEq44"><alternatives><tex-math id="M111">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$i$$\end{document}</tex-math><mml:math id="M112"><mml:mi>i</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq44.gif"/></alternatives></inline-formula>-th sequence, the relative importance <inline-formula id="IEq45"><alternatives><tex-math id="M113">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha_{ij}$$\end{document}</tex-math><mml:math id="M114"><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq45.gif"/></alternatives></inline-formula> of the <inline-formula id="IEq46"><alternatives><tex-math id="M115">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$j$$\end{document}</tex-math><mml:math id="M116"><mml:mi>j</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq46.gif"/></alternatives></inline-formula>-th residue is <inline-formula id="IEq47"><alternatives><tex-math id="M117">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\alpha_{ij}$$\end{document}</tex-math><mml:math id="M118"><mml:msub><mml:mi>α</mml:mi><mml:mrow><mml:mi mathvariant="italic">ij</mml:mi></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq47.gif"/></alternatives></inline-formula>. <inline-formula id="IEq48"><alternatives><tex-math id="M119">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$att\left( {h_{i} } \right)$$\end{document}</tex-math><mml:math id="M120"><mml:mrow><mml:mi>a</mml:mi><mml:mi>t</mml:mi><mml:mi>t</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq48.gif"/></alternatives></inline-formula> is the weighted sum of each row of <inline-formula id="IEq49"><alternatives><tex-math id="M121">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$h_{i}$$\end{document}</tex-math><mml:math id="M122"><mml:msub><mml:mi>h</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq49.gif"/></alternatives></inline-formula> (information for each residue). <inline-formula id="IEq50"><alternatives><tex-math id="M123">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$n $$\end{document}</tex-math><mml:math id="M124"><mml:mi>n</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq50.gif"/></alternatives></inline-formula> is the number of units in the Bi-LSTM layer.</p>
        </sec>
        <sec id="Sec15">
          <title>Self-attention mechanism</title>
          <p id="Par33">Self-attention, is an attention mechanism relating different positions of a single sequence in order to compute a representation of the sequence<sup><xref ref-type="bibr" rid="CR34">34</xref></sup>. Using the self-attention mechanism, the relationship between any two residues in a peptide sequence can be directly established, regardless of the distance between them. Two residues that are far apart in the sequence may be relatively close in space and to some extent have an internal connection, so we considered using self-attention mechanism to establish the relationship between any two residues. The self-attention mechanism can be implemented using the "SeqSelfAttention" function in Keras, and its mathematical description is as follows:<disp-formula id="Equ12"><label>12</label><alternatives><tex-math id="M125">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {h_{{t,t^{\prime}}} = \tanh \left( {x_{t}^{T} W_{t} + x_{{t^{\prime}}}^{T} W_{x} + b_{t} } \right) } \\ \end{array} $$\end{document}</tex-math><mml:math id="M126" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mo>tanh</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:mi>t</mml:mi></mml:mrow><mml:mi>T</mml:mi></mml:msubsup><mml:msub><mml:mi>W</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msubsup><mml:mi>x</mml:mi><mml:mrow><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow><mml:mi>T</mml:mi></mml:msubsup><mml:msub><mml:mi>W</mml:mi><mml:mi>x</mml:mi></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ12.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ13"><label>13</label><alternatives><tex-math id="M127">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {e_{{t,t^{\prime}}} = \sigma \left( {W_{a} h_{{t,t^{\prime}}} + b_{a} } \right)} \\ \end{array} $$\end{document}</tex-math><mml:math id="M128" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>e</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:msub><mml:mo>=</mml:mo><mml:mi>σ</mml:mi><mml:mfenced close=")" open="("><mml:mrow><mml:msub><mml:mi>W</mml:mi><mml:mi>a</mml:mi></mml:msub><mml:msub><mml:mi>h</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:msub><mml:mo>+</mml:mo><mml:msub><mml:mi>b</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:mrow></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ13.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ14"><label>14</label><alternatives><tex-math id="M129">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {a_{t} = softmax\left( {e_{t} } \right) } \\ \end{array} $$\end{document}</tex-math><mml:math id="M130" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:mi>s</mml:mi><mml:mi>o</mml:mi><mml:mi>f</mml:mi><mml:mi>t</mml:mi><mml:mi>m</mml:mi><mml:mi>a</mml:mi><mml:mi>x</mml:mi><mml:mfenced close=")" open="("><mml:msub><mml:mi>e</mml:mi><mml:mi>t</mml:mi></mml:msub></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ14.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ15"><label>15</label><alternatives><tex-math id="M131">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {l_{t} = \mathop \sum \limits_{{t^{\prime}}} a_{{t,t^{\prime}}} x_{{t^{\prime}}}  } \\ \end{array} $$\end{document}</tex-math><mml:math id="M132" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:msub><mml:mi>l</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>=</mml:mo><mml:munder><mml:mo movablelimits="false">∑</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:munder><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:msub><mml:msub><mml:mi>x</mml:mi><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:msub></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ15.gif" position="anchor"/></alternatives></disp-formula>
where <inline-formula id="IEq51"><alternatives><tex-math id="M133">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{t} \in {\mathbb{R}}^{{L_{max} }}$$\end{document}</tex-math><mml:math id="M134"><mml:mrow><mml:msub><mml:mi>a</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:msub><mml:mi>L</mml:mi><mml:mrow><mml:mi mathvariant="italic">max</mml:mi></mml:mrow></mml:msub></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq51.gif"/></alternatives></inline-formula>, <inline-formula id="IEq52"><alternatives><tex-math id="M135">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$x_{t} \in {\mathbb{R}}^{{ 2n}}$$\end{document}</tex-math><mml:math id="M136"><mml:mrow><mml:msub><mml:mi>x</mml:mi><mml:mi>t</mml:mi></mml:msub><mml:mo>∈</mml:mo><mml:msup><mml:mrow><mml:mi mathvariant="double-struck">R</mml:mi></mml:mrow><mml:mrow><mml:mn>2</mml:mn><mml:mi>n</mml:mi></mml:mrow></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq52.gif"/></alternatives></inline-formula> represents the output of the Bi-LSTM layer at time <inline-formula id="IEq53"><alternatives><tex-math id="M137">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$t$$\end{document}</tex-math><mml:math id="M138"><mml:mi>t</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq53.gif"/></alternatives></inline-formula> and the value <inline-formula id="IEq54"><alternatives><tex-math id="M139">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$a_{{t,t^{\prime}}} $$\end{document}</tex-math><mml:math id="M140"><mml:msub><mml:mi>a</mml:mi><mml:mrow><mml:mi>t</mml:mi><mml:mo>,</mml:mo><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mrow></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq54.gif"/></alternatives></inline-formula> represents the relative importance of the input at the <inline-formula id="IEq55"><alternatives><tex-math id="M141">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$t^{\prime}$$\end{document}</tex-math><mml:math id="M142"><mml:msup><mml:mi>t</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq55.gif"/></alternatives></inline-formula>-th position to the input at the <inline-formula id="IEq56"><alternatives><tex-math id="M143">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$t$$\end{document}</tex-math><mml:math id="M144"><mml:mi>t</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq56.gif"/></alternatives></inline-formula>-th position.</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec16">
      <title>Model overview</title>
      <sec id="Sec17">
        <title>BMF-basic</title>
        <p id="Par35">Firstly, consider the use of a Bi-LSTM model: the first layer is a Bidirectional LSTM layer; the second layer is a fully connected layer, which further extracts and synthesizes the output of the LSTM layer; the last layer is a fully connected layer whose activation function is set to softmax. The output of the final layer is the probability of being predicted to belong to ACPs or non-ACPs. The flow chart is shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>A. The Bidirectional LSTM model is a relatively basic architecture, which we call it BMF-Basic.<fig id="Fig1"><label>Figure 1</label><caption><p>The framework of the proposed ACPred-BMF with multi feature representations. We proposed two models: (<bold>A</bold>)BMF-Basic and (<bold>B</bold>)BMF-Selfatt. For BMF-Basic and BMF-Selfatt, we all used the feature combination of BPF, Quanc and Qualc to numerical representation for peptide sequences. The red box marks the difference between the two models: whether to include the attention layers or not.</p></caption><graphic xlink:href="41598_2022_24404_Fig1_HTML" id="MO1"/></fig></p>
      </sec>
      <sec id="Sec18">
        <title>BMF-selfatt</title>
        <p id="Par36">We further considered adding attention mechanism, including ordinary attention and self-attention. We added the self-attention layer after the Bi-LSTM layer to establish the relationship between any two residues and the Attention layer after the self-attention layer to calculate the weighted sum of residue information at different positions. Same as BMF-Basic, the last two layers of the model are fully connected layers. The schematic diagram of the model is shown in Fig. <xref rid="Fig1" ref-type="fig">1</xref>B. Compared with BMF-Basic, this method is more complex, has more model parameters, and is more refined in the processing of sequences. We call it BMF-Selfatt.</p>
      </sec>
    </sec>
    <sec id="Sec19">
      <title>Evaluation metrics and methods</title>
      <p id="Par37">To comprehensively evaluate the model performance, this study has taken into account Accuracy (ACC), sensitivity (Sen), specificity (Spc), Matthew’s correlation coefficient (MCC) and area under ROC curve (AUC). These evaluation metrics are defined in the following equations:<disp-formula id="Equ16"><label>16</label><alternatives><tex-math id="M145">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {ACC = \frac{TP + TN}{{TP + TN + FP + FN}} \times 100\% } \\ \end{array} $$\end{document}</tex-math><mml:math id="M146" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>A</mml:mi><mml:mi>C</mml:mi><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ16.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ17"><label>17</label><alternatives><tex-math id="M147">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {Sen = \frac{TP}{{TP + FN}} \times 100\% } \\ \end{array} $$\end{document}</tex-math><mml:math id="M148" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>S</mml:mi><mml:mi>e</mml:mi><mml:mi>n</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">TP</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ17.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ18"><label>18</label><alternatives><tex-math id="M149">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {Spc = \frac{TN}{{TN + FP}} \times 100\%  } \\ \end{array} $$\end{document}</tex-math><mml:math id="M150" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>S</mml:mi><mml:mi>p</mml:mi><mml:mi>c</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi mathvariant="italic">TN</mml:mi></mml:mrow><mml:mrow><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfrac><mml:mo>×</mml:mo><mml:mn>100</mml:mn><mml:mo>%</mml:mo></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ18.gif" position="anchor"/></alternatives></disp-formula><disp-formula id="Equ19"><label>19</label><alternatives><tex-math id="M151">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {MCC = \frac{TP \times TN - FP \times FN}{{\sqrt {\left( {TP + FP} \right) \times \left( {TP + FN} \right) \times \left( {TN + FP} \right) \times \left( {TN + FN} \right)} }} } \\ \end{array} $$\end{document}</tex-math><mml:math id="M152" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>M</mml:mi><mml:mi>C</mml:mi><mml:mi>C</mml:mi><mml:mo>=</mml:mo><mml:mfrac><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>×</mml:mo><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>-</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi><mml:mo>×</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow><mml:msqrt><mml:mrow><mml:mfenced close=")" open="("><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi>T</mml:mi><mml:mi>P</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>P</mml:mi></mml:mrow></mml:mfenced><mml:mo>×</mml:mo><mml:mfenced close=")" open="("><mml:mrow><mml:mi>T</mml:mi><mml:mi>N</mml:mi><mml:mo>+</mml:mo><mml:mi>F</mml:mi><mml:mi>N</mml:mi></mml:mrow></mml:mfenced></mml:mrow></mml:msqrt></mml:mfrac></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equ19.gif" position="anchor"/></alternatives></disp-formula>
where TP, TN, FP and FN represent true positive, true negative, false positive and false negative, respectively. Corresponding to the concrete problem of ACP prediction: TP is the number of ACPs that are correctly predicted; TN is the number of non-ACPs that are correctly predicted. FP is the number of non-ACPs that are predicted as ACPs; FN is the number of ACPs that are predicted as non-ACPs.</p>
      <p id="Par39">MCC is an overall performance evaluation metric of the quality of binary classification, which returns a value between − 1 and + 1. The higher the MCC value achieves, the better the performance of the prediction model is. AUC is defined as the area enclosed by the coordinate axis and the ROC curve, which returns a value between 0 and 1. When the AUC value closes to 1, the prediction model is regarded as a better one. Among them, MCC is a very stringent metric by taking into account both accuracy and error rates of the two classes<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>. Therefore, we regarded MCC as the most important metric for feature selection, model selection and model optimization.</p>
    </sec>
  </sec>
  <sec id="Sec20">
    <title>Results</title>
    <sec id="Sec21">
      <title>Initial results</title>
      <p id="Par40">To select better numerical representations for peptide sequences and deep learning models, we used the two frameworks (BMF-Basic, BMF-Selfatt) to develop 2 models for each feature combination, a total of 8 models have been developed. We conducted experiments on both the main and alternate datasets, selected features and models through five-fold cross-validation results.</p>
      <sec id="Sec22">
        <title>Initial performance of models trained on the main dataset</title>
        <p id="Par41">For the main dataset, with epochs fixed to 65, the results are shown in Table <xref rid="Tab4" ref-type="table">4</xref>. It shows that under the premise of using the same feature combination, BMF-Basic has better cross-validation scores (MCC, ACC, AUC) than BMF-Selfatt. The BMF-Basic based on the BPF + Quanc + Qualc feature combination (mix) achieved the best cross-validation MCC (0.497) and ACC (74.75%) as compared with other combination of features and models. In addition, the BMF-Selfatt model using feature combinations of more than just BPF (quanc, qualc, mix) all have better cross-validation scores than the BMF-Selfatt model only using BPF except for Spc. For the BMF-Basic model, the BPF + Quanc + Qualc feature combination (mix) also has a higher cross-validation scores than the bpf except Sen. This shows that the addition of prior information of amino acids on the basis of BPF representation is helpful for ACP prediction, which may be due to the more comprehensive characterization of peptide sequences.<table-wrap id="Tab4"><label>Table 4</label><caption><p>The initial five-fold cross-validation results of models developed on main dataset.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left">Feature combination</th><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th><th align="left">AUC</th></tr></thead><tbody><tr><td align="left" rowspan="4">Basic</td><td align="left">bpf</td><td char="." align="char">74.60</td><td char="." align="char">76.05</td><td char="." align="char">73.15</td><td char="." align="char">0.493</td><td char="." align="char">0.823</td></tr><tr><td align="left">quanc</td><td char="." align="char">74.24</td><td char="." align="char">72.56</td><td char="." align="char">75.92</td><td char="." align="char">0.488</td><td char="." align="char">0.822</td></tr><tr><td align="left">qualc</td><td char="." align="char">73.44</td><td char="." align="char">72.86</td><td char="." align="char">74.03</td><td char="." align="char">0.470</td><td char="." align="char">0.815</td></tr><tr><td align="left">mix</td><td char="." align="char"><bold>74.75</bold></td><td char="." align="char"><bold>73.72</bold></td><td char="." align="char"><bold>75.77</bold></td><td char="." align="char"><bold>0.497</bold></td><td char="." align="char"><bold>0.825</bold></td></tr><tr><td align="left" rowspan="4">Selfatt</td><td align="left">bpf</td><td char="." align="char">72.28</td><td char="." align="char">70.10</td><td char="." align="char">74.45</td><td char="." align="char">0.449</td><td char="." align="char">0.801</td></tr><tr><td align="left">quanc</td><td char="." align="char"><bold>73.37</bold></td><td char="." align="char"><bold>74.16</bold></td><td char="." align="char"><bold>72.58</bold></td><td char="." align="char"><bold>0.469</bold></td><td char="." align="char"><bold>0.802</bold></td></tr><tr><td align="left">qualc</td><td char="." align="char">73.00</td><td char="." align="char">75.60</td><td char="." align="char">70.39</td><td char="." align="char">0.463</td><td char="." align="char">0.812</td></tr><tr><td align="left">mix</td><td char="." align="char">72.64</td><td char="." align="char">71.83</td><td char="." align="char">73.44</td><td char="." align="char">0.456</td><td char="." align="char">0.820</td></tr></tbody></table><table-wrap-foot><p>The BMF-Basic and BMF-Selfatt initial results with the best five-fold cross-validation MCC are marked in bold.</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec23">
        <title>Initial performance of models trained on the alternate dataset</title>
        <p id="Par42">The same experiment was also performed on the alternate dataset, with epochs fixed to 35, and the cross-validation results are shown in Table <xref rid="Tab5" ref-type="table">5</xref>. It shows that whether it is BMF-Basic or BMF-Selfatt, using the BPF + Quanc + Qualc feature combination (mix) has better five-fold cross-validation scores except for Spc or Sen. Among them, BMF-Basic five-fold cross-validation scores of five metrics (MCC = 0.826, ACC = 91.24%, Sen = 91.75%, Spc = 90.72%, AUC = 0.965) were all better than the BMF-Selfatt (MCC = 0.781, ACC = 88.92%, Sen = 87.76%, Spc = 90.07%, AUC = 0.961).It can also be seen from the results that on the basis of BPF, with the same model the sequence representation using the physicochemical properties of amino acids achieves better five-fold cross-validation MCC, ACC, and AUC except for Selfatt model based on qualc.<table-wrap id="Tab5"><label>Table 5</label><caption><p>The initial five-fold cross-validation results of models developed on alternate dataset.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Model</th><th align="left">Feature combination</th><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th><th align="left">AUC</th></tr></thead><tbody><tr><td align="left" rowspan="4">Basic</td><td align="left">bpf</td><td char="." align="char">88.40</td><td char="." align="char">88.79</td><td char="." align="char">88.01</td><td char="." align="char">0.770</td><td char="." align="char">0.949</td></tr><tr><td align="left">quanc</td><td char="." align="char">90.34</td><td char="." align="char">89.82</td><td char="." align="char">90.85</td><td char="." align="char">0.808</td><td char="." align="char">0.961</td></tr><tr><td align="left">qualc</td><td char="." align="char">89.24</td><td char="." align="char">90.85</td><td char="." align="char">87.62</td><td char="." align="char">0.786</td><td char="." align="char">0.957</td></tr><tr><td align="left">mix</td><td char="." align="char"><bold>91.24</bold></td><td char="." align="char"><bold>91.75</bold></td><td char="." align="char"><bold>90.72</bold></td><td char="." align="char"><bold>0.826</bold></td><td char="." align="char"><bold>0.965</bold></td></tr><tr><td align="left" rowspan="4">Selfatt</td><td align="left">bpf</td><td char="." align="char">88.47</td><td char="." align="char">88.14</td><td char="." align="char">88.78</td><td char="." align="char">0.771</td><td char="." align="char">0.951</td></tr><tr><td align="left">quanc</td><td char="." align="char">88.60</td><td char="." align="char">90.46</td><td char="." align="char">86.72</td><td char="." align="char">0.775</td><td char="." align="char">0.956</td></tr><tr><td align="left">qualc</td><td char="." align="char">87.24</td><td char="." align="char">89.30</td><td char="." align="char">85.18</td><td char="." align="char">0.748</td><td char="." align="char">0.948</td></tr><tr><td align="left">mix</td><td char="." align="char"><bold>88.92</bold></td><td char="." align="char"><bold>87.76</bold></td><td char="." align="char"><bold>90.07</bold></td><td char="." align="char"><bold>0.781</bold></td><td char="." align="char"><bold>0.961</bold></td></tr></tbody></table><table-wrap-foot><p>The BMF-Basic and BMF-Selfatt initial results with the best five-fold cross-validation MCC are marked in bold.</p></table-wrap-foot></table-wrap></p>
      </sec>
      <sec id="Sec24">
        <title>Comparison of initial results of models</title>
        <p id="Par43">In the initial results of the model, we first noticed that the use of prior information such as quantitative and qualitative properties of amino acids on the basis of BPF can effectively represent peptide sequences.</p>
        <p id="Par44">Secondly, it can be observed from the results in Tables <xref rid="Tab4" ref-type="table">4</xref> and <xref rid="Tab5" ref-type="table">5</xref> that the BMF-Basic model performs better five-fold cross-validation results than BMF-Selfatt model whether it is developed on the main dataset or the alternate dataset.
</p>
        <p id="Par45">Additionally, the results show that the effective feature combination are the same in the two datasets, whose experimental results are shown in Table <xref rid="Tab6" ref-type="table">6</xref>. Whether in the main dataset or alternate dataset, using the BPF + Quanc + Qualc feature combination (mix) to numerically represent the peptide sequence works best.<table-wrap id="Tab6"><label>Table 6</label><caption><p>Comparison of initial cross-validation results of the models developed on the main dataset and alternate dataset.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Dataset</th><th align="left">Model</th><th align="left">Feature combination</th><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th><th align="left">AUC</th></tr></thead><tbody><tr><td align="left">Main</td><td align="left">Basic</td><td align="left">mix</td><td char="." align="char">74.75</td><td char="." align="char">73.72</td><td char="." align="char">75.77</td><td char="." align="char">0.497</td><td char="." align="char">0.825</td></tr><tr><td align="left">Alternate</td><td align="left">Basic</td><td align="left">mix</td><td char="." align="char">91.24</td><td char="." align="char">91.75</td><td char="." align="char">90.72</td><td char="." align="char">0.826</td><td char="." align="char">0.965</td></tr></tbody></table></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec25">
      <title>Comparison of numerical representation and embedding methods</title>
      <p id="Par46">We also made a comparison and selection between our proposed numerical representation method and the embedding method through five-fold cross-validation results. Embedding methods utilize peptide sequences information to numerically represent peptide sequences without using known prior information. Specifically, for each amino acid, it is randomly initialized into a <inline-formula id="IEq57"><alternatives><tex-math id="M153">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{0}$$\end{document}</tex-math><mml:math id="M154"><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq57.gif"/></alternatives></inline-formula>-dimensional vector. Further through model training, the <inline-formula id="IEq58"><alternatives><tex-math id="M155">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{0}$$\end{document}</tex-math><mml:math id="M156"><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq58.gif"/></alternatives></inline-formula>-dimensional vector is adaptively adjusted<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. For a fair comparison, we set embedding and the numerical representation to have the same dimension, i.e. <inline-formula id="IEq59"><alternatives><tex-math id="M157">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$d_{0} = 36$$\end{document}</tex-math><mml:math id="M158"><mml:mrow><mml:msub><mml:mi>d</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>=</mml:mo><mml:mn>36</mml:mn></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq59.gif"/></alternatives></inline-formula>. Other model parameters are the same as numerical representation method, and the cross-validation results are shown in Table <xref rid="Tab7" ref-type="table">7</xref>. On the main dataset, our representation method achieves better five-fold cross-validation scores (MCC = 0.497, ACC = 74.75%) than embedding method (MCC = 0.477, ACC = 73.73%). On the alternate dataset, the five-fold cross-validation scores of 5 metrics achieved by our representation method are all better than the embedding method. And because our representation has biological significance, while the specific meaning of each dimension of the vector obtained by the embedding method is unknown, as shown in the “Explainable prediction” section, our representation method is more interpretable than the embedding method. The results show that our proposed representation has advantages to some extent compared with the embedding method, indicating that using some prior information is beneficial to ACP prediction.<table-wrap id="Tab7"><label>Table 7</label><caption><p>Five-fold cross-validation results of the numerical representation and embedding method.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Dataset</th><th align="left">Model</th><th align="left">Feature combination</th><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th><th align="left">AUC</th></tr></thead><tbody><tr><td align="left" rowspan="2">Main</td><td align="left" rowspan="4">Basic</td><td align="left">mix</td><td char="." align="char">74.75</td><td char="." align="char">73.72</td><td char="." align="char">75.77</td><td char="." align="char">0.497</td><td char="." align="char">0.825</td></tr><tr><td align="left">Embedding</td><td char="." align="char">73.73</td><td char="." align="char">74.75</td><td char="." align="char">72.72</td><td char="." align="char">0.477</td><td char="." align="char">0.815</td></tr><tr><td align="left" rowspan="2">Alternate</td><td align="left">mix</td><td char="." align="char">91.24</td><td char="." align="char">91.75</td><td char="." align="char">90.72</td><td char="." align="char">0.826</td><td char="." align="char">0.965</td></tr><tr><td align="left">Embedding</td><td char="." align="char">87.95</td><td char="." align="char">89.04</td><td char="." align="char">86.85</td><td char="." align="char">0.761</td><td char="." align="char">0.946</td></tr></tbody></table></table-wrap></p>
    </sec>
    <sec id="Sec26">
      <title>Model optimization</title>
      <p id="Par47">According to the above results, we optimized the model (the BMF-Basic with the BPF + Quanc + Qualc feature combination) which achieves the best initial results. We used the hyper-parameter grid search method to determine the optimal model based on the main and alternate datasets.</p>
      <sec id="Sec27">
        <title>Main dataset model optimization</title>
        <p id="Par48">The experimental results of the five-fold cross-validation are shown in Supplementary data <xref rid="MOESM1" ref-type="media">S1</xref>. It can be observed that when the number of units in the Bi-LSTM layer is 64, the number of neurons in the first fully connected layer is 50, and the number of epochs is 45, the model has the best cross-validation MCC (0.516). Table <xref rid="Tab8" ref-type="table">8</xref> shows the five-fold cross-validation and independent test results corresponding to the optimal model. On the main dataset, the model realized the independent test results of MCC = 0.623 and ACC = 80.81%. And the ROC curve for optimized model based on main dataset is shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>A.<table-wrap id="Tab8"><label>Table 8</label><caption><p>The performance of optimized models based on the main dataset and alternate dataset.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left">Dataset</th><th align="left" colspan="5">Five-fold cross-validation</th><th align="left" colspan="5">Independent test</th></tr><tr><th align="left"/><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th><th align="left">AUC</th><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th><th align="left">AUC</th></tr></thead><tbody><tr><td align="left">Main</td><td char="." align="char">75.76</td><td char="." align="char">76.93</td><td char="." align="char">74.60</td><td char="." align="char">0.516</td><td char="." align="char">0.827</td><td char="." align="char">80.81</td><td char="." align="char">88.37</td><td char="." align="char">73.26</td><td char="." align="char">0.623</td><td char="." align="char">0.861</td></tr><tr><td align="left">Alternate</td><td char="." align="char">91.49</td><td char="." align="char">90.85</td><td char="." align="char">92.14</td><td char="." align="char">0.831</td><td char="." align="char">0.968</td><td char="." align="char">93.56</td><td char="." align="char">92.27</td><td char="." align="char">94.85</td><td char="." align="char">0.871</td><td char="." align="char">0.974</td></tr></tbody></table><table-wrap-foot><p>The optimized model uses BMF-Basic with BPF + Quanc + Qualc feature combination (mix).</p></table-wrap-foot></table-wrap><fig id="Fig2"><label>Figure 2</label><caption><p>ROC curve of the optimized model over independent test set. (<bold>A</bold>)The ROC curve of the optimized model on the main dataset. (<bold>B</bold>)The ROC curve of the optimized model on the alternate dataset.</p></caption><graphic xlink:href="41598_2022_24404_Fig2_HTML" id="MO2"/></fig></p>
      </sec>
      <sec id="Sec28">
        <title>Analysis of optimization results</title>
        <p id="Par49">The experimental results of the five-fold cross-validation are shown in Supplementary data S2. On the alternate dataset, when the number of units in the Bi-LSTM is 128, the number of neurons in the first fully connected layer is 50, and the number of epochs is 35, there is the best five-fold cross-validation MCC (0.831). The five-fold cross-validation and independent test results of the optimized model are shown in Table <xref rid="Tab8" ref-type="table">8</xref>. The optimized model performed AUC of 0.974 on the test dataset, as shown in Fig. <xref rid="Fig2" ref-type="fig">2</xref>B.</p>
        <p id="Par50">After model optimization, the model applied on the main dataset has a higher number of epochs, while the model on the alternate dataset has fewer epochs. After our analysis, we got a similar view to He et al.<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>, which may be due to the difference in the task difficulty itself between the two datasets: on the main dataset, ACPs and AMPs need to be distinguished; On the alternate dataset, ACPs need to be distinguished from random peptides. Relatively speaking, the range of AMPs is smaller, the discrimination between ACPs and AMPs is smaller, for ACPs are part of the AMP group<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> and the task is more difficult, requiring more epochs to train. Distinguishing ACPs from random peptides is relatively simple, and the model requires fewer epochs.</p>
        <p id="Par51">In addition, we also tested models on the non-redundant test sets, in which sequences similar to training sets were removed. The original test datasets all have sequences similar to the training sets. For example, the main training data includes the sequence “GLFDIVKKVVGTIAGL”, and the test data includes a similar sequence “GLFDIVKKVVGTLAGL”. In order to obtain more objective results, we used CD-HIT-2D in the CD-HIT program<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> to compare the training set with the test set, and retain the test set sequence that is not similar to the training set sequence (below the sequence identity threshold) for independent testing using the optimized models. According to the facts that if a protein sequence has 40% or more similarity to another with a known function, it is highly probable that both perform the same function<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> and at the same time according to the thresholds used in the references, we conducted experiments on three thresholds: 40%<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>, 80%<sup><xref ref-type="bibr" rid="CR20">20</xref></sup> and 90%<sup><xref ref-type="bibr" rid="CR19">19</xref>,<xref ref-type="bibr" rid="CR54">54</xref></sup> (Table <xref rid="Tab9" ref-type="table">9</xref>).<table-wrap id="Tab9"><label>Table 9</label><caption><p>Independent test results on non-redundant datasets (sequence identity threshold: 100%, 90%, 80%, 40%).</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Threshold</th><th align="left" colspan="4">Main dataset</th><th align="left" colspan="4">Alternate dataset</th></tr><tr><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th></tr></thead><tbody><tr><td align="left">100%</td><td char="." align="char">80.81</td><td char="." align="char">88.37</td><td char="." align="char">73.26</td><td char="." align="char">0.62</td><td char="." align="char">93.56</td><td char="." align="char">92.27</td><td char="." align="char">94.85</td><td char="." align="char">0.87</td></tr><tr><td align="left">90%</td><td char="." align="char">78.54</td><td char="." align="char">84.31</td><td char="." align="char">74.05</td><td char="." align="char">0.58</td><td char="." align="char">92.38</td><td char="." align="char">88.43</td><td char="." align="char">94.85</td><td char="." align="char">0.84</td></tr><tr><td align="left">80%</td><td char="." align="char">75.90</td><td char="." align="char">80.56</td><td char="." align="char">72.34</td><td char="." align="char">0.52</td><td char="." align="char">92.03</td><td char="." align="char">85.54</td><td char="." align="char">94.82</td><td char="." align="char">0.81</td></tr><tr><td align="left">40%</td><td char="." align="char">72.73</td><td char="." align="char">46.15</td><td char="." align="char">90.00</td><td char="." align="char">0.41</td><td char="." align="char">95.24</td><td char="." align="char">86.36</td><td char="." align="char">96.80</td><td char="." align="char">0.82</td></tr></tbody></table></table-wrap></p>
        <p id="Par52">After removing redundancy, the independent test MCC of the two models all decrease. When the threshold value is set at 90%, the independent testing MCC and ACC on the main dataset are 0.04 and 2.27% lower than the original independent testing results; compared with the original independent test results, the independent testing MCC and ACC on the alternate dataset decrease by 0.03 and 1.18%. When the threshold is 90%, the independent testing scores decrease slightly. The big drop in independent test scores is the model based on the main dataset, when tested on the test set with 40% threshold. In addition to the performance of the model itself, it may also be related to the small amount of data (only 33 sequences remain after the main test set is de redundant with 40% threshold), which may not be representative. When the threshold value is 40%, the independent test scores obtained on the alternate dataset not change much compared with the original independent test scores: MCC decreases by 0.05 and ACC increases by 1.68%. It shows that our model has good prediction performance on non-redundant test sets, and has generalization ability.</p>
      </sec>
    </sec>
    <sec id="Sec29">
      <title>Network feature visualization</title>
      <p id="Par53">Deep learning-based methods can automatically extract features<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. To demonstrate the effectiveness of the model in extracting features, we further visualized the optimized model. Specifically, we output the result of the penultimate layer of the network (that is, the first fully connected layer) to obtain a high-dimensional feature. High-dimensional features cannot be directly visualized. Principal component analysis (PCA)<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> obtains a new variable, the principal component, by linearly transforming the original variable, and maximizes the variance of the principal component to contain more information. In this way, most information can be concentrated in the previous principal components, and the use of principal component analysis can effectively reduce dimensionality. We use PCA<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> dimensionality reduction technique to reduce our obtained high-dimensional features to 2 dimensions to facilitate visualization. Figure <xref rid="Fig3" ref-type="fig">3</xref>A and B show the discriminatory effect of automatically extracted features on the main dataset and the alternate dataset, respectively. At the beginning (epochs = 1), the points representing ACPs and non-ACPs are mixed together because the parameters of the neural network are randomly initialized. After training (epochs = 35/45), the ACPs and non-ACPs in the training set can be well distinguished by the features automatically extracted by the optimized models. The extracted features can effectively distinguish ACPs from non-ACPs in the test set even if the network does not use the data in the test set during training. This shows that the models we trained have learned some common features, not just the features that distinguish ACPs from non-ACPs on the training set, and the models are generalizable to some extent.<fig id="Fig3"><label>Figure 3</label><caption><p>Feature visualization by PCA for dimension reduction. (<bold>A</bold>) Dimension reduction of each sample on the main dataset. (<bold>B</bold>) Dimension reduction of each sample on the alternate dataset. The horizontal axis represents the first principal component, and the vertical axis represents the second principal component. The numbers in brackets of the horizontal and vertical axis labels indicate the explained variance ratio of the corresponding principal components. Pink points represent ACPs, while light blue points represent non-ACPs.</p></caption><graphic xlink:href="41598_2022_24404_Fig3_HTML" id="MO3"/></fig></p>
    </sec>
    <sec id="Sec30">
      <title>Explainable predictions</title>
      <p id="Par54">At present, the prediction method based on deep learning has promoted the development of ACP prediction, but deep learning has the underlying black-box nature, which is reflected in that it is difficult to know its prediction mechanism and further explore after getting the results of the model. It arises from the fact that, despite having the underlying statistical principles, there is a lack of ability to explicitly represent the knowledge for a given task performed by a deep neural network<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Intelligibility means that the model is easily understandable<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>. The explicability of the model is important for ACP prediction, it can provide an explanation on the underlying mechanism of the biological activity of ACPs, which is more useful to further analyze the characteristics of the anticancer activity of peptides<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>, thus promoting the discovery of more ACPs. Secondly, explicability can enhance the reliability of the model. A machine learning algorithm should be considered reliable in the way it allows to extract more knowledge and information than just having a prediction at hand<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Thirdly, explicability is the key to trust-able use of the deep learning model and a key enabler for its deployment in the real world<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. By showing how the model makes decisions can inculcate trust among the end-users<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>. Last but not least, considering that the model will be extended to peptides with different biological activities in the future, the main features of peptides with different functions can be identified by utilizing the explicability, thus promoting the development of peptide drugs.</p>
      <p id="Par55">Based on the above considerations, we further analyzed the results using SHAP (Sharply Additive exPlanations)<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> to interpret our model and alleviate the black-box prediction problem in deep learning, which is a generalized metric for feature importance and utilizes the game-theory-based Shapely value to calculate the contribution of each feature to the model’s output<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>. The SHAP formula is:<disp-formula id="Equa"><alternatives><tex-math id="M159">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$ \begin{array}{*{20}c} {g\left( {z^{\prime}} \right) = \phi_{0} + \mathop \sum \limits_{i = 1}^{M} \phi_{i} z_{i} ^{\prime} \left( {20} \right)} \\ \end{array} $$\end{document}</tex-math><mml:math id="M160" display="block"><mml:mrow><mml:mtable><mml:mtr><mml:mtd><mml:mrow><mml:mi>g</mml:mi><mml:mfenced close=")" open="("><mml:msup><mml:mi>z</mml:mi><mml:mo>′</mml:mo></mml:msup></mml:mfenced><mml:mo>=</mml:mo><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>0</mml:mn></mml:msub><mml:mo>+</mml:mo><mml:munderover><mml:mo movablelimits="false">∑</mml:mo><mml:mrow><mml:mi>i</mml:mi><mml:mo>=</mml:mo><mml:mn>1</mml:mn></mml:mrow><mml:mi>M</mml:mi></mml:munderover><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>i</mml:mi></mml:msub><mml:msubsup><mml:mi>z</mml:mi><mml:mrow><mml:mi>i</mml:mi></mml:mrow><mml:mo>′</mml:mo></mml:msubsup><mml:mfenced close=")" open="("><mml:mn>20</mml:mn></mml:mfenced></mml:mrow></mml:mtd></mml:mtr></mml:mtable></mml:mrow></mml:math><graphic xlink:href="41598_2022_24404_Article_Equa.gif" position="anchor"/></alternatives></disp-formula>
where <inline-formula id="IEq60"><alternatives><tex-math id="M161">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$g$$\end{document}</tex-math><mml:math id="M162"><mml:mi>g</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq60.gif"/></alternatives></inline-formula> is the explanatory model, which approximates the output of the original model; <inline-formula id="IEq61"><alternatives><tex-math id="M163">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$M$$\end{document}</tex-math><mml:math id="M164"><mml:mi>M</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq61.gif"/></alternatives></inline-formula> is the number of input features; <inline-formula id="IEq62"><alternatives><tex-math id="M165">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$z^{\prime} \in \left\{ {0,1} \right\}^{M}$$\end{document}</tex-math><mml:math id="M166"><mml:mrow><mml:msup><mml:mi>z</mml:mi><mml:mo>′</mml:mo></mml:msup><mml:mo>∈</mml:mo><mml:msup><mml:mfenced close="}" open="{"><mml:mrow><mml:mn>0</mml:mn><mml:mo>,</mml:mo><mml:mn>1</mml:mn></mml:mrow></mml:mfenced><mml:mi>M</mml:mi></mml:msup></mml:mrow></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq62.gif"/></alternatives></inline-formula> indicates whether the corresponding feature exists; <inline-formula id="IEq63"><alternatives><tex-math id="M167">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\phi_{i}$$\end{document}</tex-math><mml:math id="M168"><mml:msub><mml:mi>ϕ</mml:mi><mml:mi>i</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq63.gif"/></alternatives></inline-formula> is the attribution value of each feature; <inline-formula id="IEq64"><alternatives><tex-math id="M169">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$\phi_{0}$$\end{document}</tex-math><mml:math id="M170"><mml:msub><mml:mi>ϕ</mml:mi><mml:mn>0</mml:mn></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq64.gif"/></alternatives></inline-formula> is a constant. That is, the sum of the Shapley values for all features plus the mean prediction equals the actual prediction<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. This is not the same as direct feature effects known from (generalised) linear models, and the SHAP value for a feature should be seen as its compound effect when interacting with the other features. We obtained the SHAP value through the shap package in Python.</p>
      <p id="Par57">We mainly analyzed the model developed on the alternate dataset for that in the alternate dataset, using random peptides as negative samples, as they are more distinguishable from ACPs and can highlight the main features of ACPs.</p>
      <p id="Par58">Figure <xref rid="Fig4" ref-type="fig">4</xref> and <xref rid="Fig5" ref-type="fig">5</xref> show the top 10 Quanc, Qualc features ranked using SHAP. Each point in Fig. <xref rid="Fig4" ref-type="fig">4</xref> represents the impact of a feature at a position on the ACP prediction for a peptide sequence. We also calculated the feature importance: take the average value of the SHAP values’ absolute values of each feature as the importance of the feature, and get a bar chart (as shown in Fig. <xref rid="Fig5" ref-type="fig">5</xref>). Figure <xref rid="Fig4" ref-type="fig">4</xref> shows that negatively charge is the first-ranked importance factor impacting ACP prediction, and lower values of this feature result in higher SHAP values, which correspond to a higher probability that a peptide sequence be an ACP. That is, negatively charged amino acids have a negative impact on the probability of being predicted to be ACPs, and positively or neutral amino acids have a positive impact. In addition, aromaticity is also an important feature, ranking fifth, and Fig. <xref rid="Fig4" ref-type="fig">4</xref> shows that aromatic amino acids have a positive impact on ACP prediction. The above analysis is consistent with existing studies: Agrawal et al.<sup><xref ref-type="bibr" rid="CR23">23</xref></sup> pointed out that ACPs are rich in positively charged residues and aromatic amino acids. The second most important feature is p <inline-formula id="IEq65"><alternatives><tex-math id="M171">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$K_{a} $$\end{document}</tex-math><mml:math id="M172"><mml:msub><mml:mi>K</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq65.gif"/></alternatives></inline-formula>(acidity coefficient), which with high value has a positive impact on ACP prediction. Existing studies have also shown that the theoretical interpretation and prediction of protein p <inline-formula id="IEq66"><alternatives><tex-math id="M173">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$K_{a}$$\end{document}</tex-math><mml:math id="M174"><mml:msub><mml:mi>K</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq66.gif"/></alternatives></inline-formula> value is helpful for understanding many biochemical problems<sup><xref ref-type="bibr" rid="CR63">63</xref></sup>. Similarly, points with higher values under the isoelectric point (the pH value when a molecule has no charge on the surface) or neutral charge feature are on the positive side of SHAP value, indicating that the higher values of these two features also correspond to a positive impact on ACP prediction. Through the SHAP algorithm, we obtained the feature importance rank based on their contribution to ACP prediction and the influence direction (positive or negative correlation) on the predicted probability of being ACPs, which is consistent with the existing research results and helps to further understand the mechanism of ACPs.<fig id="Fig4"><label>Figure 4</label><caption><p>The impact of the features on ACP prediction. The <inline-formula id="IEq68"><alternatives><tex-math id="M175">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$x$$\end{document}</tex-math><mml:math id="M176"><mml:mi>x</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq68.gif"/></alternatives></inline-formula>-axis of the figure labeled as the SHAP value (impact on model output), and the <inline-formula id="IEq69"><alternatives><tex-math id="M177">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$y$$\end{document}</tex-math><mml:math id="M178"><mml:mi>y</mml:mi></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq69.gif"/></alternatives></inline-formula>-axis, listing the top 10 features, are ranked based on their contribution to the ACP prediction. The red color corresponds to high value of the features consisting of Quanc and Qualc, whereas the blue color corresponds to low value of the features. The naming of features is consistent with the aforementioned numerical representation, such as "charge_N" means a feature without charge (neutral charge feature).</p></caption><graphic xlink:href="41598_2022_24404_Fig4_HTML" id="MO4"/></fig><fig id="Fig5"><label>Figure 5</label><caption><p>Feature importance rank using the SHAP method. The figure shows the top ten features with the highest importance, where the longer the bars’ length is, the more important or the more contribution of the feature for ACP prediction.</p></caption><graphic xlink:href="41598_2022_24404_Fig5_HTML" id="MO5"/></fig></p>
    </sec>
    <sec id="Sec31">
      <title>Comparison with the existing methods</title>
      <p id="Par59">We also compared our ACPred-BMF predictor to the existing methods on independent test sets. The independent testing results for state-of-the-art ACP prediction directly came from references<sup><xref ref-type="bibr" rid="CR23">23</xref>,<xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR58">58</xref></sup>. The results are shown in Table <xref rid="Tab10" ref-type="table">10</xref>. In the main dataset, the MCC and accuracy (0.62, 80.81%) of our method are only lower than iACP-FSCM, whose MCC and accuracy are 0.65, 82.5%. The Spc (73.26%) of ACPred-BMF ranked fifth, but its Sen (88.37%) ranked second. Only the Sen (100%) of the AntiCP is higher than ACPred- BMF, but the MCC of the AntiCP is only 0.07. ACPred-BMF has both high Sen and ACC, so it is less likely to miss the real ACPs on the premise of high overall accuracy. In the alternate dataset, MCC and the accuracy (0.87, 93.56%) of our method ACPred-BMF achieve the best prediction performance compared with other methods. ACPred-BMF discriminates ACPs and non-ACPs with balanced Sen (92.27%) and Spc (94.85%).<table-wrap id="Tab10"><label>Table 10</label><caption><p>Comparison of the independent testing metrics values for ACPred-BMF with state-of-the-art ACP predictors on the main and alternate datasets.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="2">Methods</th><th align="left" colspan="4">Main dataset</th><th align="left" colspan="4">Alternate dataset</th></tr><tr><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th><th align="left">ACC (%)</th><th align="left">Sen (%)</th><th align="left">Spc (%)</th><th align="left">MCC</th></tr></thead><tbody><tr><td align="left">ACPred-BMF</td><td char="." align="char">80.81</td><td char="." align="char">88.37</td><td char="." align="char">73.26</td><td char="." align="char">0.62</td><td char="." align="char">93.56</td><td char="." align="char">92.27</td><td char="." align="char">94.85</td><td char="." align="char">0.87</td></tr><tr><td align="left">AntiCP-2.0</td><td char="." align="char">75.43</td><td char="." align="char">77.46</td><td char="." align="char">73.41</td><td char="." align="char">0.51</td><td char="." align="char">92.01</td><td char="." align="char">92.27</td><td char="." align="char">91.75</td><td char="." align="char">0.84</td></tr><tr><td align="left">AntiCP</td><td char="." align="char">50.58</td><td char="." align="char">100.00</td><td char="." align="char">1.16</td><td char="." align="char">0.07</td><td char="." align="char">89.95</td><td char="." align="char">89.69</td><td char="." align="char">90.20</td><td char="." align="char">0.80</td></tr><tr><td align="left">ACPred</td><td char="." align="char">53.47</td><td char="." align="char">85.55</td><td char="." align="char">21.39</td><td char="." align="char">0.09</td><td char="." align="char">85.31</td><td char="." align="char">87.11</td><td char="." align="char">83.51</td><td char="." align="char">0.71</td></tr><tr><td align="left">ACPred-FL</td><td char="." align="char">44.80</td><td char="." align="char">67.05</td><td char="." align="char">22.54</td><td char="." align="char"> − 0.12</td><td char="." align="char">43.80</td><td char="." align="char">60.21</td><td char="." align="char">25.58</td><td char="." align="char"> − 0.15</td></tr><tr><td align="left">ACPpred-Fuse</td><td char="." align="char">68.90</td><td char="." align="char">69.19</td><td char="." align="char">68.60</td><td char="." align="char">0.38</td><td char="." align="char">78.87</td><td char="." align="char">64.43</td><td char="." align="char">93.30</td><td char="." align="char">0.60</td></tr><tr><td align="left">PEPred-Suite</td><td char="." align="char">53.49</td><td char="." align="char">33.14</td><td char="." align="char">73.84</td><td char="." align="char">0.08</td><td char="." align="char">57.47</td><td char="." align="char">40.21</td><td char="." align="char">74.74</td><td char="." align="char">0.16</td></tr><tr><td align="left">iACP</td><td char="." align="char">55.10</td><td char="." align="char">77.91</td><td char="." align="char">32.16</td><td char="." align="char">0.11</td><td char="." align="char">77.58</td><td char="." align="char">78.35</td><td char="." align="char">76.80</td><td char="." align="char">0.55</td></tr><tr><td align="left">iACPred-FSCM</td><td char="." align="char">82.50</td><td char="." align="char">72.60</td><td char="." align="char">90.30</td><td char="." align="char">0.65</td><td char="." align="char">88.90</td><td char="." align="char">87.60</td><td char="." align="char">90.20</td><td char="." align="char">0.78</td></tr><tr><td align="left">ACPred-LAF</td><td char="." align="char">79.07</td><td char="." align="char">81.98</td><td char="." align="char">76.16</td><td char="." align="char">0.58</td><td char="." align="char">93.30</td><td char="." align="char">93.30</td><td char="." align="char">93.30</td><td char="." align="char">0.87</td></tr><tr><td align="left">ACP-MHCNN</td><td char="." align="char">73.00</td><td char="." align="char">78.50</td><td char="." align="char">67.40</td><td char="." align="char">0.46</td><td char="." align="char">90.00</td><td char="." align="char">86.60</td><td char="." align="char">86.60</td><td char="." align="char">0.81</td></tr></tbody></table></table-wrap></p>
      <p id="Par60">Although iACP-FSCM has a better independent test MCC, Spc and ACC on the main dataset than ACPred-BMF, ACPred-BMF has better test scores (MCC, ACC, Sen, Spc) than iACP-FSCM on the alternate dataset. Considering that more data are used and more kinds of peptides are involved in the future, our proposed deep learning based-model is more adaptable: deep learning is data-driven, highly dependent on data, and in general, the larger the amount of data, the better its performance within limits; deep learning has strong adaptability and can learn very complex functions with the composition of enough such transformations<sup><xref ref-type="bibr" rid="CR29">29</xref></sup>. Compared with other models except for iACP-FSCM, ACPred-BMF has better independent test performance and explainability, and can give important features for prediction.</p>
      <p id="Par61">The observed results show that our method, ACPred-BMF, is one of the state-of-the-art predictors based on machine learning and deep learning methods.</p>
    </sec>
  </sec>
  <sec id="Sec32">
    <title>Conclusion</title>
    <p id="Par62">Compared with traditional treatment methods, ACPs have great therapeutic potential. However, experimentally identifying ACPs is time-consuming, laborious and expensive. We investigated this problem and proposed a predictor called ACPred-BMF that uses the Bi-LSTM network and a new numerical representation for peptide sequences. In terms of the numerical representation for peptide sequences, we characterized peptide sequences from the perspectives of using prior biological knowledge and retaining original information. We used BPF, quantitative and qualitative properties of amino acids and their combinations to represent peptide sequences. For the model, we considered two network architectures without and with attention: BMF-Basic, BMF-Selfatt. The results show that the BMF-Basic performs better five-fold cross-validation effects for the experimental data in this paper. We also visualized the features automatically extracted by the network, showing that the feature can well distinguish ACPs from non-ACPs. Using the SHAP technique, we further interpreted the model and found that features such as charge, p <inline-formula id="IEq67"><alternatives><tex-math id="M179">\documentclass[12pt]{minimal}
				\usepackage{amsmath}
				\usepackage{wasysym} 
				\usepackage{amsfonts} 
				\usepackage{amssymb} 
				\usepackage{amsbsy}
				\usepackage{mathrsfs}
				\usepackage{upgreek}
				\setlength{\oddsidemargin}{-69pt}
				\begin{document}$$K_{a}$$\end{document}</tex-math><mml:math id="M180"><mml:msub><mml:mi>K</mml:mi><mml:mi>a</mml:mi></mml:msub></mml:math><inline-graphic xlink:href="41598_2022_24404_Article_IEq67.gif"/></alternatives></inline-formula>, and aromaticity play an important role in predicting ACPs.</p>
    <p id="Par63">In future work, we will use more complex models such as transformers<sup><xref ref-type="bibr" rid="CR34">34</xref></sup> to adapt more complex problems, such as multifunctional classification of peptides. In addition, it can also be considered to assign different weights to features and residues at different positions through the attention mechanism to obtain a weighted numerical representation of the peptide sequences. By definition, a counterfactual is the smallest variation of the input such that it changes the predicted behaviour<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>. Furthermore, we can consider combining counterfactual theory to design ACP, that is, by appropriately modifying the sequence of non-ACP to make it have anti-cancer activity.</p>
    <p id="Par64">Experimental results show that our proposed predictor, ACPred-BMF, is quite competitive with existing prediction methods and is one of the state-of-the-art ACP predictors. Our study provides new ideas for the prediction of ACPs, especially on deep learning-based methods for ACP prediction. Besides, a web server as the implementation of ACPred-BMF can be accessed via: <ext-link ext-link-type="uri" xlink:href="http://mialab.ruc.edu.cn/ACPredBMFServer/">http://mialab.ruc.edu.cn/ACPredBMFServer/</ext-link>.</p>
  </sec>
  <sec sec-type="supplementary-material">
    <title>Supplementary Information</title>
    <sec id="Sec33">
      <p>
        <supplementary-material content-type="local-data" id="MOESM1">
          <media xlink:href="41598_2022_24404_MOESM1_ESM.pdf">
            <caption>
              <p>Supplementary Information.</p>
            </caption>
          </media>
        </supplementary-material>
      </p>
    </sec>
  </sec>
</body>
<back>
  <fn-group>
    <fn>
      <p>
        <bold>Publisher's note</bold>
      </p>
      <p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p>
    </fn>
  </fn-group>
  <sec>
    <title>Supplementary Information</title>
    <p>The online version contains supplementary material available at 10.1038/s41598-022-24404-1.</p>
  </sec>
  <ack>
    <title>Acknowledgements</title>
    <p>This work was supported by the National Natural Science Foundation of China (No. 31670725), National Natural Science Foundation of China [11931008], National Key Research and Development Program of China [2020YFA0712400] and Public Computing Cloud, Renmin University of China.</p>
  </ack>
  <notes notes-type="author-contribution">
    <title>Author contributions</title>
    <p>B.H. developed the algorithm and performed the experiment. B.H., N.Z. wrote the manuscript. N.Z. helped with feature visualization and figure drawing. C.Z. designed the online server. Z.M., X.G. designed the project, mentored and analytically reviewed the paper. All authors read and approved the final manuscript.</p>
  </notes>
  <notes notes-type="data-availability">
    <title>Data availability</title>
    <p>The authors confirm that the data generated or analysed during this study are included in this article and its supplementary information files. The specific prediction results in this study are available at <ext-link ext-link-type="uri" xlink:href="http://mialab.ruc.edu.cn/ACPredBMFServer/">http://mialab.ruc.edu.cn/ACPredBMFServer/</ext-link>.</p>
  </notes>
  <notes id="FPar1" notes-type="COI-statement">
    <title>Competing interests</title>
    <p id="Par65">The authors declare no competing interests.</p>
  </notes>
  <ref-list id="Bib1">
    <title>References</title>
    <ref id="CR1">
      <label>1.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Siegel</surname>
            <given-names>RL</given-names>
          </name>
          <name>
            <surname>Miller</surname>
            <given-names>KD</given-names>
          </name>
          <name>
            <surname>Fuchs</surname>
            <given-names>HE</given-names>
          </name>
          <name>
            <surname>Jemal</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cancer statistics, 2022</article-title>
        <source>CA Cancer J. Clin.</source>
        <year>2022</year>
        <volume>72</volume>
        <fpage>7</fpage>
        <lpage>33</lpage>
        <pub-id pub-id-type="doi">10.3322/caac.21708</pub-id>
        <pub-id pub-id-type="pmid">35020204</pub-id>
      </element-citation>
    </ref>
    <ref id="CR2">
      <label>2.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Peptide-based cancer therapy: Opportunity and challenge</article-title>
        <source>Cancer Lett.</source>
        <year>2014</year>
        <volume>351</volume>
        <fpage>13</fpage>
        <lpage>22</lpage>
        <pub-id pub-id-type="doi">10.1016/j.canlet.2014.05.002</pub-id>
        <pub-id pub-id-type="pmid">24836189</pub-id>
      </element-citation>
    </ref>
    <ref id="CR3">
      <label>3.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Amit</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Hochberg</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Development of targeted therapy for bladder cancer mediated by a double promoter plasmid expressing diphtheria toxin under the control of H19 and IGF2-P4 regulatory sequences</article-title>
        <source>J. Trans. Med.</source>
        <year>2010</year>
        <volume>8</volume>
        <fpage>134</fpage>
        <pub-id pub-id-type="doi">10.1186/1479-5876-8-134</pub-id>
      </element-citation>
    </ref>
    <ref id="CR4">
      <label>4.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Peer</surname>
            <given-names>D</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Nanocarriers as an emerging platform for cancer therapy</article-title>
        <source>Nat. Nanotechnol.</source>
        <year>2007</year>
        <volume>2</volume>
        <fpage>751</fpage>
        <pub-id pub-id-type="doi">10.1038/nnano.2007.387</pub-id>
        <pub-id pub-id-type="pmid">18654426</pub-id>
      </element-citation>
    </ref>
    <ref id="CR5">
      <label>5.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chiangjong</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Chutipongtanate</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hongeng</surname>
            <given-names>S</given-names>
          </name>
        </person-group>
        <article-title>Anticancer peptide: Physicochemical property, functional aspect and trend in clinical application (Review)</article-title>
        <source>Int. J. Oncol.</source>
        <year>2020</year>
        <volume>57</volume>
        <fpage>678</fpage>
        <lpage>696</lpage>
        <pub-id pub-id-type="doi">10.3892/ijo.2020.5099</pub-id>
        <pub-id pub-id-type="pmid">32705178</pub-id>
      </element-citation>
    </ref>
    <ref id="CR6">
      <label>6.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Pfeffer</surname>
            <given-names>CM</given-names>
          </name>
          <name>
            <surname>Singh</surname>
            <given-names>ATK</given-names>
          </name>
        </person-group>
        <article-title>Apoptosis: A target for anticancer therapy</article-title>
        <source>Int. J. Mol. Sci.</source>
        <year>2018</year>
        <volume>19</volume>
        <fpage>448</fpage>
        <pub-id pub-id-type="doi">10.3390/ijms19020448</pub-id>
        <pub-id pub-id-type="pmid">29393886</pub-id>
      </element-citation>
    </ref>
    <ref id="CR7">
      <label>7.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gabernet</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Müller</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Hiss</surname>
            <given-names>JA</given-names>
          </name>
          <name>
            <surname>Schneider</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Membranolytic anticancer peptides</article-title>
        <source>Medchemcomm.</source>
        <year>2016</year>
        <volume>10</volume>
        <fpage>2232</fpage>
        <lpage>2245</lpage>
        <pub-id pub-id-type="doi">10.1039/C6MD00376A</pub-id>
      </element-citation>
    </ref>
    <ref id="CR8">
      <label>8.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Sok</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sentjurc</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Schara</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Membrane fluidity characteristics of human lung cancer</article-title>
        <source>Cancer let.</source>
        <year>1999</year>
        <volume>139</volume>
        <issue>2</issue>
        <fpage>215</fpage>
        <lpage>220</lpage>
        <pub-id pub-id-type="doi">10.1016/S0304-3835(99)00044-0</pub-id>
        <pub-id pub-id-type="pmid">10395181</pub-id>
      </element-citation>
    </ref>
    <ref id="CR9">
      <label>9.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hoskin</surname>
            <given-names>DW</given-names>
          </name>
          <name>
            <surname>Ramamoorthy</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Studies on anticancer activities of antimicrobial peptides</article-title>
        <source>BBA-Biomembr.</source>
        <year>2008</year>
        <volume>1778</volume>
        <fpage>357</fpage>
        <lpage>375</lpage>
        <pub-id pub-id-type="doi">10.1016/j.bbamem.2007.11.008</pub-id>
      </element-citation>
    </ref>
    <ref id="CR10">
      <label>10.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Fisher</surname>
            <given-names>E</given-names>
          </name>
          <name>
            <surname>Pavlenko</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Vlasov</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Ramenskaya</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Peptide-based therapeutics for oncology</article-title>
        <source>Pharmaceut. Med.</source>
        <year>2019</year>
        <volume>33</volume>
        <fpage>9</fpage>
        <lpage>20</lpage>
        <pub-id pub-id-type="doi">10.1007/s40290-018-0261-7</pub-id>
        <pub-id pub-id-type="pmid">31933267</pub-id>
      </element-citation>
    </ref>
    <ref id="CR11">
      <label>11.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Perez</surname>
            <given-names>SA</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>A new era in anticancer peptide vaccines</article-title>
        <source>Cancer</source>
        <year>2010</year>
        <volume>116</volume>
        <fpage>2071</fpage>
        <lpage>2080</lpage>
        <pub-id pub-id-type="pmid">20187092</pub-id>
      </element-citation>
    </ref>
    <ref id="CR12">
      <label>12.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Gautam</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Chaudhary</surname>
            <given-names>K</given-names>
          </name>
          <name>
            <surname>Kumar</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>In silico approaches for designing highly effective cell penetrating peptides</article-title>
        <source>J. Trans. Med.</source>
        <year>2013</year>
        <volume>11</volume>
        <fpage>74</fpage>
        <pub-id pub-id-type="doi">10.1186/1479-5876-11-74</pub-id>
      </element-citation>
    </ref>
    <ref id="CR13">
      <label>13.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tyagi</surname>
            <given-names>A</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>In silico models for designing and discovering novel anticancer peptides</article-title>
        <source>Sci. Rep.</source>
        <year>2013</year>
        <volume>3</volume>
        <fpage>2984</fpage>
        <pub-id pub-id-type="doi">10.1038/srep02984</pub-id>
        <pub-id pub-id-type="pmid">24136089</pub-id>
      </element-citation>
    </ref>
    <ref id="CR14">
      <label>14.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Vijayakumar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Ptv</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>ACPP: A web server for prediction and design of anti-cancer peptides</article-title>
        <source>Int. J. Pept. Res. Ther.</source>
        <year>2014</year>
        <volume>21</volume>
        <fpage>99</fpage>
        <lpage>106</lpage>
        <pub-id pub-id-type="doi">10.1007/s10989-014-9435-7</pub-id>
      </element-citation>
    </ref>
    <ref id="CR15">
      <label>15.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chen</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Ding</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Feng</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Lin</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Chou</surname>
            <given-names>KC</given-names>
          </name>
        </person-group>
        <article-title>iACP: A sequence-based tool for identifying anticancer peptides</article-title>
        <source>Oncotarget</source>
        <year>2016</year>
        <volume>7</volume>
        <issue>13</issue>
        <fpage>16895</fpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.7815</pub-id>
        <pub-id pub-id-type="pmid">26942877</pub-id>
      </element-citation>
    </ref>
    <ref id="CR16">
      <label>16.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Akbar</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Hayat</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Iqbal</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Jan</surname>
            <given-names>MA</given-names>
          </name>
        </person-group>
        <article-title>iACP-GAEnsC: Evolutionary genetic algorithm based ensemble classification of anticancer peptides by utilizing hybrid feature space</article-title>
        <source>Artif. Intell. Med.</source>
        <year>2017</year>
        <volume>79</volume>
        <fpage>62</fpage>
        <lpage>70</lpage>
        <pub-id pub-id-type="doi">10.1016/j.artmed.2017.06.008</pub-id>
        <pub-id pub-id-type="pmid">28655440</pub-id>
      </element-citation>
    </ref>
    <ref id="CR17">
      <label>17.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>K</given-names>
          </name>
        </person-group>
        <article-title>Using amphiphilic pseudo amino acid composition to predict enzyme subfamily classes</article-title>
        <source>Bioinformatics</source>
        <year>2005</year>
        <volume>21</volume>
        <fpage>10</fpage>
        <lpage>19</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bth466</pub-id>
        <pub-id pub-id-type="pmid">15308540</pub-id>
      </element-citation>
    </ref>
    <ref id="CR18">
      <label>18.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Balachandran</surname>
            <given-names>M</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>MLACP: Machine-learning-based prediction of anticancer peptides</article-title>
        <source>Oncotarget</source>
        <year>2017</year>
        <volume>8</volume>
        <issue>44</issue>
        <fpage>77121</fpage>
        <pub-id pub-id-type="doi">10.18632/oncotarget.20365</pub-id>
        <pub-id pub-id-type="pmid">29100375</pub-id>
      </element-citation>
    </ref>
    <ref id="CR19">
      <label>19.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Chen</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Song</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>R</given-names>
          </name>
        </person-group>
        <article-title>ACPred-FL: A sequence-based predictor using effective feature representation to improve the prediction of anti-cancer peptides</article-title>
        <source>Bioinformatics</source>
        <year>2018</year>
        <volume>34</volume>
        <fpage>4007</fpage>
        <lpage>4016</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/bty451</pub-id>
        <pub-id pub-id-type="pmid">29868903</pub-id>
      </element-citation>
    </ref>
    <ref id="CR20">
      <label>20.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Rao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zhou</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>(2019) ACPred-Fuse: Fusing multi-view information improves the prediction of anticancer peptides</article-title>
        <source>Brief. Bioinform.</source>
        <year>1846</year>
        <volume>21</volume>
        <fpage>5</fpage>
      </element-citation>
    </ref>
    <ref id="CR21">
      <label>21.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schaduangrat</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Nantasenamat</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Prachayasittikul</surname>
            <given-names>V</given-names>
          </name>
          <name>
            <surname>Shoombuatong</surname>
            <given-names>W</given-names>
          </name>
        </person-group>
        <article-title>ACPred: A computational tool for the prediction and analysis of anticancer peptides</article-title>
        <source>Molecules</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.3390/molecules24101973</pub-id>
      </element-citation>
    </ref>
    <ref id="CR22">
      <label>22.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Chou</surname>
            <given-names>KC</given-names>
          </name>
        </person-group>
        <article-title>Some remarks on protein attribute prediction and pseudo amino acid composition</article-title>
        <source>J. Theor. Biol.</source>
        <year>2011</year>
        <volume>273</volume>
        <fpage>236</fpage>
        <lpage>247</lpage>
        <pub-id pub-id-type="doi">10.1016/j.jtbi.2010.12.024</pub-id>
        <pub-id pub-id-type="pmid">21168420</pub-id>
      </element-citation>
    </ref>
    <ref id="CR23">
      <label>23.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Agrawal</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Bhagat</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mahalwal</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Sharma</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Raghava</surname>
            <given-names>GPS</given-names>
          </name>
        </person-group>
        <article-title>AntiCP 2.0: An updated model for predicting anticancer peptides</article-title>
        <source>Brief. Bioinform.</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1093/bib/bbaa153</pub-id>
      </element-citation>
    </ref>
    <ref id="CR24">
      <label>24.</label>
      <mixed-citation publication-type="other">Bahdanau, D., Cho, K. &amp; Bengio, Y. Neural Machine Translation by Jointly Learning to Align and Translate. <italic>3rd International Conference on Learning Representations</italic> (2015).</mixed-citation>
    </ref>
    <ref id="CR25">
      <label>25.</label>
      <mixed-citation publication-type="other">Hassan, A. &amp; Mahmood, A. Deep learning for sentence classification. <italic>2017 IEEE Long Island Systems, Applications and Technology Conference (LISAT)</italic>. 1–5 (2017).</mixed-citation>
    </ref>
    <ref id="CR26">
      <label>26.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Ahmed</surname>
            <given-names>S</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ACP-MHCNN: An accurate multi-headed deep-convolutional neural network to predict anticancer peptides</article-title>
        <source>Sci. Rep.</source>
        <year>2021</year>
        <volume>11</volume>
        <fpage>23676</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-021-02703-3</pub-id>
        <pub-id pub-id-type="pmid">34880291</pub-id>
      </element-citation>
    </ref>
    <ref id="CR27">
      <label>27.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>He</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Wang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Su</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Wei</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Learning embedding features based on multi-sense-scaled attention architecture to improve the predictive performance of anticancer peptides</article-title>
        <source>Bioinformatics</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btab560</pub-id>
      </element-citation>
    </ref>
    <ref id="CR28">
      <label>28.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Yi</surname>
            <given-names>HC</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>ACP-DL: A deep learning long short-term memory model to predict anticancer peptides using high-efficiency feature representation</article-title>
        <source>Mol. Ther. Nucleic Acids</source>
        <year>2019</year>
        <volume>17</volume>
        <fpage>1</fpage>
        <lpage>9</lpage>
        <pub-id pub-id-type="doi">10.1016/j.omtn.2019.04.025</pub-id>
        <pub-id pub-id-type="pmid">31173946</pub-id>
      </element-citation>
    </ref>
    <ref id="CR29">
      <label>29.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>LeCun</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Bengio</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Hinton</surname>
            <given-names>G</given-names>
          </name>
        </person-group>
        <article-title>Deep learning</article-title>
        <source>Nature</source>
        <year>2015</year>
        <volume>521</volume>
        <fpage>436</fpage>
        <lpage>444</lpage>
        <pub-id pub-id-type="doi">10.1038/nature14539</pub-id>
        <pub-id pub-id-type="pmid">26017442</pub-id>
      </element-citation>
    </ref>
    <ref id="CR30">
      <label>30.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lv</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Cui</surname>
            <given-names>F</given-names>
          </name>
          <name>
            <surname>Zou</surname>
            <given-names>Q</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>L</given-names>
          </name>
          <name>
            <surname>Xu</surname>
            <given-names>L</given-names>
          </name>
        </person-group>
        <article-title>Anticancer peptides prediction with deep representation learning features</article-title>
        <source>Brief. Bioinform.</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1093/bib/bbab008</pub-id>
      </element-citation>
    </ref>
    <ref id="CR31">
      <label>31.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Wu</surname>
            <given-names>C</given-names>
          </name>
          <name>
            <surname>Gao</surname>
            <given-names>R</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>De Marinis</surname>
            <given-names>Y</given-names>
          </name>
        </person-group>
        <article-title>PTPD: Predicting therapeutic peptides by deep learning and word2vec</article-title>
        <source>BMC Bioinform.</source>
        <year>2019</year>
        <pub-id pub-id-type="doi">10.1186/s12859-019-3006-z</pub-id>
      </element-citation>
    </ref>
    <ref id="CR32">
      <label>32.</label>
      <mixed-citation publication-type="other">Mikolov, T., Chen, K., Corrado, G. &amp; Dean, J. Efficient Estimation of Word Representations in Vector Space. <italic>ICLR</italic> (2013).</mixed-citation>
    </ref>
    <ref id="CR33">
      <label>33.</label>
      <mixed-citation publication-type="other">Mikolov, T., Sutskever, I., Chen, K., Corrado, G. &amp; Dean, J. Distributed Representations of Words and Phrases and Their Compositionality. <italic>Nips'13</italic>, 3111–3119 (2013).</mixed-citation>
    </ref>
    <ref id="CR34">
      <label>34.</label>
      <mixed-citation publication-type="other">Vaswani, A. et al. Attention is All You Need. <italic>Nips'17</italic>, 6000–6010 (2017).</mixed-citation>
    </ref>
    <ref id="CR35">
      <label>35.</label>
      <mixed-citation publication-type="other">T.W.G. Solomons, <italic>Organic Chemistry</italic>, 6th ed., John Wiley &amp; Sons, Inc., New York (1996).</mixed-citation>
    </ref>
    <ref id="CR36">
      <label>36.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Mcsheehy</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lu</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Mester</surname>
            <given-names>Z</given-names>
          </name>
        </person-group>
        <article-title>Selenomethionine extraction from selenized yeast: An LC-MS study of the acid hydrolysis of a synthetic selenopeptide</article-title>
        <source>Microchim. Acta</source>
        <year>2006</year>
        <volume>155</volume>
        <fpage>373</fpage>
        <lpage>377</lpage>
        <pub-id pub-id-type="doi">10.1007/s00604-006-0520-2</pub-id>
      </element-citation>
    </ref>
    <ref id="CR37">
      <label>37.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Liu</surname>
            <given-names>HX</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Prediction of the isoelectric point of an amino acid based on GA-PLS and SVMs</article-title>
        <source>J. Chem. Inf. Comput.</source>
        <year>2004</year>
        <volume>44</volume>
        <fpage>161</fpage>
        <lpage>167</lpage>
        <pub-id pub-id-type="doi">10.1021/ci034173u</pub-id>
      </element-citation>
    </ref>
    <ref id="CR38">
      <label>38.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Idrees</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Mohammad</surname>
            <given-names>AR</given-names>
          </name>
          <name>
            <surname>Karodia</surname>
            <given-names>N</given-names>
          </name>
          <name>
            <surname>Rahman</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Multimodal role of amino acids in microbial control and drug development</article-title>
        <source>Antibiotics</source>
        <year>2020</year>
        <volume>9</volume>
        <issue>6</issue>
        <fpage>330</fpage>
        <pub-id pub-id-type="doi">10.3390/antibiotics9060330</pub-id>
        <pub-id pub-id-type="pmid">32560458</pub-id>
      </element-citation>
    </ref>
    <ref id="CR39">
      <label>39.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Matveev</surname>
            <given-names>YI</given-names>
          </name>
          <name>
            <surname>Grinberg</surname>
            <given-names>VY</given-names>
          </name>
          <name>
            <surname>Sochava</surname>
            <given-names>IV</given-names>
          </name>
          <name>
            <surname>Tolstoguzov</surname>
            <given-names>VB</given-names>
          </name>
        </person-group>
        <article-title>Glass transition temperature of proteins. Calculation based on the additive contribution method and experimental data</article-title>
        <source>Food Hydrocolloids</source>
        <year>1997</year>
        <volume>11</volume>
        <fpage>125</fpage>
        <lpage>133</lpage>
        <pub-id pub-id-type="doi">10.1016/S0268-005X(97)80020-3</pub-id>
      </element-citation>
    </ref>
    <ref id="CR40">
      <label>40.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Dou</surname>
            <given-names>Y</given-names>
          </name>
          <name>
            <surname>Yao</surname>
            <given-names>B</given-names>
          </name>
          <name>
            <surname>Zhang</surname>
            <given-names>C</given-names>
          </name>
        </person-group>
        <article-title>PhosphoSVM: Prediction of phosphorylation sites by integrating various protein sequence attributes with a support vector machine</article-title>
        <source>Amino Acids</source>
        <year>2014</year>
        <volume>46</volume>
        <fpage>1459</fpage>
        <lpage>1469</lpage>
        <pub-id pub-id-type="doi">10.1007/s00726-014-1711-5</pub-id>
        <pub-id pub-id-type="pmid">24623121</pub-id>
      </element-citation>
    </ref>
    <ref id="CR41">
      <label>41.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Cohen</surname>
            <given-names>JD</given-names>
          </name>
          <name>
            <surname>Servan-Schreiber</surname>
            <given-names>D</given-names>
          </name>
          <name>
            <surname>Mcclelland</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>A parallel distributed processing approach to automaticity</article-title>
        <source>Am. J. Psychol.</source>
        <year>1992</year>
        <volume>105</volume>
        <fpage>239</fpage>
        <lpage>269</lpage>
        <pub-id pub-id-type="doi">10.2307/1423029</pub-id>
        <pub-id pub-id-type="pmid">1621882</pub-id>
      </element-citation>
    </ref>
    <ref id="CR42">
      <label>42.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Elman</surname>
            <given-names>JL</given-names>
          </name>
        </person-group>
        <article-title>Finding structure in time</article-title>
        <source>Cogn. Sci.</source>
        <year>1990</year>
        <volume>14</volume>
        <fpage>179</fpage>
        <lpage>211</lpage>
        <pub-id pub-id-type="doi">10.1207/s15516709cog1402_1</pub-id>
      </element-citation>
    </ref>
    <ref id="CR43">
      <label>43.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hochreiter</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Schmidhuber</surname>
            <given-names>J</given-names>
          </name>
        </person-group>
        <article-title>Long short-term memory</article-title>
        <source>Neural Comput.</source>
        <year>1997</year>
        <volume>9</volume>
        <fpage>1735</fpage>
        <lpage>1780</lpage>
        <pub-id pub-id-type="doi">10.1162/neco.1997.9.8.1735</pub-id>
        <pub-id pub-id-type="pmid">9377276</pub-id>
      </element-citation>
    </ref>
    <ref id="CR44">
      <label>44.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Comp</surname>
            <given-names>N</given-names>
          </name>
        </person-group>
        <article-title>Learning To Forget: Continual Prediction With LSTM</article-title>
        <source>Neural Comput.</source>
        <year>2000</year>
        <volume>12</volume>
        <fpage>2451</fpage>
        <lpage>2471</lpage>
        <pub-id pub-id-type="doi">10.1162/089976600300015015</pub-id>
        <pub-id pub-id-type="pmid">11032042</pub-id>
      </element-citation>
    </ref>
    <ref id="CR45">
      <label>45.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Schuster</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Paliwal</surname>
            <given-names>KK</given-names>
          </name>
        </person-group>
        <article-title>Bidirectional recurrent neural networks</article-title>
        <source>IEEE Trans. Signal Process.</source>
        <year>1997</year>
        <volume>45</volume>
        <fpage>2673</fpage>
        <lpage>2681</lpage>
        <pub-id pub-id-type="doi">10.1109/78.650093</pub-id>
      </element-citation>
    </ref>
    <ref id="CR46">
      <label>46.</label>
      <mixed-citation publication-type="other">Cho, K. <italic>et al.</italic> Learning phrase representations using RNN encoder-decoder for statistical machine translation. In <italic>Conference on Empirical Methods in Natural Language Processing</italic> 1724–1734 (2014).</mixed-citation>
    </ref>
    <ref id="CR47">
      <label>47.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>RensinkRonald</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>The dynamic representation of scenes</article-title>
        <source>Vis. Cognit.</source>
        <year>2000</year>
        <volume>7</volume>
        <fpage>17</fpage>
        <lpage>42</lpage>
        <pub-id pub-id-type="doi">10.1080/135062800394667</pub-id>
      </element-citation>
    </ref>
    <ref id="CR48">
      <label>48.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Corbetta</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Shulman</surname>
            <given-names>GL</given-names>
          </name>
        </person-group>
        <article-title>Control of goal-directed and stimulus-driven attention in the brain</article-title>
        <source>Nat. Rev. Neurosci.</source>
        <year>2002</year>
        <volume>3</volume>
        <fpage>201</fpage>
        <pub-id pub-id-type="doi">10.1038/nrn755</pub-id>
        <pub-id pub-id-type="pmid">11994752</pub-id>
      </element-citation>
    </ref>
    <ref id="CR49">
      <label>49.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Niu</surname>
            <given-names>Z</given-names>
          </name>
          <name>
            <surname>Zhong</surname>
            <given-names>G</given-names>
          </name>
          <name>
            <surname>Yu</surname>
            <given-names>H</given-names>
          </name>
        </person-group>
        <article-title>A review on the attention mechanism of deep learning</article-title>
        <source>Neurocomputing</source>
        <year>2021</year>
        <volume>452</volume>
        <fpage>48</fpage>
        <lpage>62</lpage>
        <pub-id pub-id-type="doi">10.1016/j.neucom.2021.03.091</pub-id>
      </element-citation>
    </ref>
    <ref id="CR50">
      <label>50.</label>
      <mixed-citation publication-type="other">Peng, Z., Wei, S., Tian, J., Qi, Z. &amp; Bo, X. Attention-Based Bidirectional Long Short-Term Memory Networks for Relation Classification. <italic>54th Annual Meeting of the Association for Computational Linguistics</italic> 2, 207–212 (2016).</mixed-citation>
    </ref>
    <ref id="CR51">
      <label>51.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Bhadra</surname>
            <given-names>P</given-names>
          </name>
          <name>
            <surname>Yan</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Li</surname>
            <given-names>J</given-names>
          </name>
          <name>
            <surname>Fong</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Siu</surname>
            <given-names>SWI</given-names>
          </name>
        </person-group>
        <article-title>AmPEP: Sequence-based prediction of antimicrobial peptides using distribution patterns of amino acid properties and random forest</article-title>
        <source>Sci. Rep.</source>
        <year>2018</year>
        <volume>8</volume>
        <fpage>1697</fpage>
        <pub-id pub-id-type="doi">10.1038/s41598-018-19752-w</pub-id>
        <pub-id pub-id-type="pmid">29374199</pub-id>
      </element-citation>
    </ref>
    <ref id="CR52">
      <label>52.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>W</given-names>
          </name>
          <name>
            <surname>Godzik</surname>
            <given-names>A</given-names>
          </name>
        </person-group>
        <article-title>Cd-hit: A fast program for clustering and comparing large sets of protein or nucleotide sequences</article-title>
        <source>Bioinformatics</source>
        <year>2006</year>
        <volume>22</volume>
        <fpage>1658</fpage>
        <lpage>1659</lpage>
        <pub-id pub-id-type="doi">10.1093/bioinformatics/btl158</pub-id>
        <pub-id pub-id-type="pmid">16731699</pub-id>
      </element-citation>
    </ref>
    <ref id="CR53">
      <label>53.</label>
      <mixed-citation publication-type="other">Petsko, G. A. &amp; Ringe, D. <italic>Protein structure and function</italic>. (New Science Press, 2004).</mixed-citation>
    </ref>
    <ref id="CR54">
      <label>54.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Tang</surname>
            <given-names>W</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Identifying multi-functional bioactive peptide functions using multi-label deep learning</article-title>
        <source>Brief. Bioinform.</source>
        <year>2022</year>
        <pub-id pub-id-type="doi">10.1093/bib/bbab414</pub-id>
      </element-citation>
    </ref>
    <ref id="CR55">
      <label>55.</label>
      <mixed-citation publication-type="other">Jolliffe, I. T. <italic>Principal component analysis for special types of data</italic>. (Springer, 2002).</mixed-citation>
    </ref>
    <ref id="CR56">
      <label>56.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Singh</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Sengupta</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lakshminarayanan</surname>
            <given-names>V</given-names>
          </name>
        </person-group>
        <article-title>Explainable deep learning models in medical image analysis</article-title>
        <source>J. Imaging</source>
        <year>2020</year>
        <volume>6</volume>
        <fpage>52</fpage>
        <pub-id pub-id-type="doi">10.3390/jimaging6060052</pub-id>
        <pub-id pub-id-type="pmid">34460598</pub-id>
      </element-citation>
    </ref>
    <ref id="CR57">
      <label>57.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Carlevaro</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mongelli</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>A New SVDD approach to reliable and explainable AI</article-title>
        <source>IEEE Intell. Syst.</source>
        <year>2022</year>
        <volume>37</volume>
        <fpage>55</fpage>
        <lpage>68</lpage>
        <pub-id pub-id-type="doi">10.1109/MIS.2021.3123669</pub-id>
      </element-citation>
    </ref>
    <ref id="CR58">
      <label>58.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Charoenkwan</surname>
            <given-names>P</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Improved prediction and characterization of anticancer activities of peptides using a novel flexible scoring card method</article-title>
        <source>Sci. Rep.</source>
        <year>2021</year>
        <pub-id pub-id-type="doi">10.1038/s41598-021-82513-9</pub-id>
      </element-citation>
    </ref>
    <ref id="CR59">
      <label>59.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Carlevaro</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Lenatti</surname>
            <given-names>M</given-names>
          </name>
          <name>
            <surname>Paglialonga</surname>
            <given-names>A</given-names>
          </name>
          <name>
            <surname>Mongelli</surname>
            <given-names>M</given-names>
          </name>
        </person-group>
        <article-title>Counterfactual building and evaluation via eXplainable support vector data description</article-title>
        <source>IEEE Access</source>
        <year>2022</year>
        <volume>10</volume>
        <fpage>60849</fpage>
        <lpage>60861</lpage>
        <pub-id pub-id-type="doi">10.1109/ACCESS.2022.3180026</pub-id>
      </element-citation>
    </ref>
    <ref id="CR60">
      <label>60.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Lundberg</surname>
            <given-names>S</given-names>
          </name>
          <name>
            <surname>Lee</surname>
            <given-names>SI</given-names>
          </name>
        </person-group>
        <article-title>A unified approach to interpreting model predictions</article-title>
        <source>Adv. Neural Inform. Process</source>
        <year>2017</year>
        <volume>30</volume>
        <fpage>4765</fpage>
        <lpage>4774</lpage>
      </element-citation>
    </ref>
    <ref id="CR61">
      <label>61.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Hartono</surname>
            <given-names>N</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>How machine learning can help select capping layers to suppress perovskite degradation</article-title>
        <source>Nat. Commun.</source>
        <year>2020</year>
        <volume>11</volume>
        <issue>1</issue>
        <fpage>1</fpage>
        <pub-id pub-id-type="pmid">31911652</pub-id>
      </element-citation>
    </ref>
    <ref id="CR62">
      <label>62.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Thorsen-Meyer</surname>
            <given-names>H-C</given-names>
          </name>
          <etal/>
        </person-group>
        <article-title>Dynamic and explainable machine learning prediction of mortality in patients in the intensive care unit: A retrospective study of high-frequency data in electronic patient records</article-title>
        <source>Lancet Digital Health</source>
        <year>2020</year>
        <volume>2</volume>
        <fpage>e179</fpage>
        <lpage>e191</lpage>
        <pub-id pub-id-type="doi">10.1016/S2589-7500(20)30018-2</pub-id>
        <pub-id pub-id-type="pmid">33328078</pub-id>
      </element-citation>
    </ref>
    <ref id="CR63">
      <label>63.</label>
      <element-citation publication-type="journal">
        <person-group person-group-type="author">
          <name>
            <surname>Li</surname>
            <given-names>H</given-names>
          </name>
          <name>
            <surname>Robertson</surname>
            <given-names>AD</given-names>
          </name>
          <name>
            <surname>Jensen</surname>
            <given-names>JH</given-names>
          </name>
        </person-group>
        <article-title>Very fast empirical prediction and rationalization of protein pKa values</article-title>
        <source>Proteins: Struct. Funct. Bioinform.</source>
        <year>2005</year>
        <volume>61</volume>
        <fpage>704</fpage>
        <lpage>721</lpage>
        <pub-id pub-id-type="doi">10.1002/prot.20660</pub-id>
      </element-citation>
    </ref>
  </ref-list>
</back>
